<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC6977312\results\search\disease\results.xml">
  <result pre="doi: 10.1186/s12941-020-0346-5 : Review The challenging management of Rift Valley" exact="Fever" post="in humans: literature review of the clinical disease and"/>
  <result pre="Rift Valley Fever in humans: literature review of the clinical" exact="disease" post="and algorithm proposal JavelleEmilieemilie.javelle@gmail.com12LesueurAlexandre1Pommier de SantiVincent23de LavalFranck34LefebvreThibault5HolweckGuillaume1DurandGuillaume AndrÃ©67Leparc-GoffartIsabelle67TexierGaÃ«tan23SimonFabrice17[1], 0000"/>
  <result pre="in a credit line to the data. Abstract Rift Valley" exact="Fever" post="(RVF) is an emerging zoonotic arbovirus with a complex"/>
  <result pre="Recent outbreaks outside Africa have led to rediscover the human" exact="disease" post="but it remains poorly known. The wide spectrum of"/>
  <result pre="disease but it remains poorly known. The wide spectrum of" exact="acute" post="and delayed manifestations with potential unfavorable outcome much complicate"/>
  <result pre="of setting of care and prolonged follow-up. Keywords Rift Valley" exact="Fever" post="Human disease Management Algorithm Background Rift Valley Fever virus"/>
  <result pre="of care and prolonged follow-up. Keywords Rift Valley Fever Human" exact="disease" post="Management Algorithm Background Rift Valley Fever virus (RVFV) is"/>
  <result pre="Rift Valley Fever Human disease Management Algorithm Background Rift Valley" exact="Fever" post="virus (RVFV) is an arbovirus, mainly transmitted by mosquitoes,"/>
  <result pre="an arbovirus, mainly transmitted by mosquitoes, responsible for a zoonosis" exact="disease" post="that affects cattle, sheep, camels and goats. It was"/>
  <result pre="aerosols produced during the slaughter of infected animals. However, human" exact="infections" post="occurred also from the bites of infected mosquitoes, mainly"/>
  <result pre="vectors. RVFV attach to cells via the interaction between the" exact="viral" post="structural proteins Gn and Gc and C-type lectins, DC-SIGN"/>
  <result pre="with the virus in the laboratory [6]. As other arboviral" exact="infections" post="including dengue, chikungunya and zika, RVF is emerging worldwide,"/>
  <result pre="in the laboratory [6]. As other arboviral infections including dengue," exact="chikungunya" post="and zika, RVF is emerging worldwide, due to the"/>
  <result pre="co-circulation [7]. The widespread presence of competent vectors, the high" exact="viral" post="load in infected animals, trade and global travel, all"/>
  <result pre="RVFV in humans are varied and unspecific including hepatitis, encephalitis," exact="hemorrhagic disease," post="and retinitis with potential dramatic consequences. The overall case"/>
  <result pre="are varied and unspecific including hepatitis, encephalitis, hemorrhagic disease, and" exact="retinitis" post="with potential dramatic consequences. The overall case fatality rate"/>
  <result pre="management. We conducted a literature review on the RVF clinical" exact="disease" post="and treatments in humans. We identified the state and"/>
  <result pre="clinical reports of RVF in humans since 1930s, i.e. â€œSouth" exact="African" post="Medical Journalâ€� and â€œTransaction of the Royal Society of"/>
  <result pre="of the World Health Organization (WHO) and the Centre for" exact="Disease" post="Control (CDC) on their official websites and the mentioned"/>
  <result pre="for figures. Epidemiology Human cases have been reported from many" exact="African" post="countries following the virus introduction via infected livestock trade"/>
  <result pre="the end of 1900s, the virus has extended outside the" exact="African" post="continent to Indian Ocean Islands: Madagascar [26], Comoros, and"/>
  <result pre="and has reached the Arabian Peninsula in 2000â€&quot;2001, with a" exact="total" post="estimated 200,000 human infections and 250 deaths in Saudi"/>
  <result pre="Arabian Peninsula in 2000â€&quot;2001, with a total estimated 200,000 human" exact="infections" post="and 250 deaths in Saudi Arabia and Yemen. During"/>
  <result pre="(WHO data as of 9 December 2019). The number of" exact="secondary" post="cases arising from a single primary case infected with"/>
  <result pre="2019). The number of secondary cases arising from a single" exact="primary" post="case infected with RVFV in an entirely susceptible population,"/>
  <result pre="reproductive ratio have some limits [34]. Fig.Â 2 Rift Valley" exact="Fever" post="distribution: endemic countries and recent outbreaks since 2000 TableÂ"/>
  <result pre="and recent outbreaks since 2000 TableÂ 1 Major Rift Valley" exact="Fever" post="outbreaks with cumulated reported human cases and confirmed deaths"/>
  <result pre="deaths over the period 2000â€&quot;2019 (WHO data [23]) Outbreaks dates" exact="Geographic" post="distribution Reported cases Cumulated reported cases Deaths confirmed Cumulated"/>
  <result pre="figures from reports as of 9th December 2019 The typical" exact="benign" post="disease Infection with RVFV is mostly pauci-symptomatic in humans."/>
  <result pre="from reports as of 9th December 2019 The typical benign" exact="disease" post="Infection with RVFV is mostly pauci-symptomatic in humans. General"/>
  <result pre="reports as of 9th December 2019 The typical benign disease" exact="Infection" post="with RVFV is mostly pauci-symptomatic in humans. General signs"/>
  <result pre="benign disease Infection with RVFV is mostly pauci-symptomatic in humans." exact="General" post="signs may occur in 50 to 95% of infected"/>
  <result pre="also reported [17, 37]. RVF differs from influenza, dengue and" exact="chikungunya" post="as to whether cough, skin involvement (i.e. rash or"/>
  <result pre="to whether cough, skin involvement (i.e. rash or pruritus) and" exact="arthritis" post="are respectively uncommon signs. A slight meningism at the"/>
  <result pre="arthritis are respectively uncommon signs. A slight meningism at the" exact="acute" post="stage is not rare, however its prognosis value has"/>
  <result pre="prognosis value has never been evaluated [37]. Basically, retro-orbital pains" exact="and neck" post="stiffness are features hard to classify because both of"/>
  <result pre="were also associated with the occurrence of complications [37, 38]." exact="Complicated" post="and severe expression Incidences of complications are uncertain because"/>
  <result pre="and severe expression Incidences of complications are uncertain because RVFV" exact="infection" post="can go unrecognized or be misdiagnosed considering the unspecific"/>
  <result pre="in 1977, it is considered that less than 5% of" exact="symptomatic" post="cases will present complications including ocular, neurologic and hemorrhagic"/>
  <result pre="the 2007 Kenyan outbreak, Kahlon et al. described a clinical" exact="syndrome" post="suggestive of severe RVF, characterized by fever, large-joint arthralgia,"/>
  <result pre="upper-quadrant pain, and delirium, often coinciding with hemorrhagic manifestations [43]." exact="Complicated" post="forms could have represented up to 20% of symptomatic"/>
  <result pre="[43]. Complicated forms could have represented up to 20% of" exact="symptomatic" post="cases during recent epidemics [36]. Morbidity, as well as"/>
  <result pre="in 2007 [19] most of RVF severe cases presented with" exact="encephalopathy" post="(respectively 71% and 89%), whereas hemorrhagic manifestations predominated in"/>
  <result pre="Madagascar in 2008 (88%) [46]. In Saudi Arabia in 2000," exact="hepatic insufficiency" post="(75%) and renal failures (41%) were the most frequent"/>
  <result pre="in 11/16 (69%) severe cases, of whom 5 (45%) had" exact="encephalitis" post="with hemorrhagic symptoms which were lethal in 2/5 (40%),"/>
  <result pre="summed-up in TableÂ 2. Fig.Â 3 Manifestations of Rift Valley" exact="Fever" post="virus infection in humans TableÂ 2 Characteristics and alternative"/>
  <result pre="in TableÂ 2. Fig.Â 3 Manifestations of Rift Valley Fever" exact="virus infection" post="in humans TableÂ 2 Characteristics and alternative diagnoses of"/>
  <result pre="TableÂ 2. Fig.Â 3 Manifestations of Rift Valley Fever virus" exact="infection" post="in humans TableÂ 2 Characteristics and alternative diagnoses of"/>
  <result pre="humans TableÂ 2 Characteristics and alternative diagnoses of Rift Valley" exact="Fever" post="manifestations RVF manifestations Time of onset Frequency Lethality Sequelae"/>
  <result pre="manifestations RVF manifestations Time of onset Frequency Lethality Sequelae Differential" exact="infectious" post="diagnoses Influenza-like syndrome 2 to 6Â days of incubation"/>
  <result pre="Time of onset Frequency Lethality Sequelae Differential infectious diagnoses Influenza-like" exact="syndrome" post="2 to 6Â days of incubation 50â€&quot;90% of infected"/>
  <result pre="6Â days of incubation 50â€&quot;90% of infected people â€&quot; Prolonged" exact="asthenia" post="Arboviruses, influenza virus, HIV (primary infection) Rickettsia spp., Coxiella"/>
  <result pre="virus, HIV (primary infection) Rickettsia spp., Coxiella burnetii, Salmonella spp.," exact="bacterial" post="sepsis Malarial parasites Acute hepatitis Day 2â€&quot;21 1â€&quot;2% of"/>
  <result pre="Rickettsia spp., Coxiella burnetii, Salmonella spp., bacterial sepsis Malarial parasites" exact="Acute" post="hepatitis Day 2â€&quot;21 1â€&quot;2% of symptomatic cases High in"/>
  <result pre="spp., Coxiella burnetii, Salmonella spp., bacterial sepsis Malarial parasites Acute" exact="hepatitis" post="Day 2â€&quot;21 1â€&quot;2% of symptomatic cases High in icteric"/>
  <result pre="bacterial sepsis Malarial parasites Acute hepatitis Day 2â€&quot;21 1â€&quot;2% of" exact="symptomatic" post="cases High in icteric hepatitis None EBV, CMV, HIV,"/>
  <result pre="hepatitis Day 2â€&quot;21 1â€&quot;2% of symptomatic cases High in icteric" exact="hepatitis" post="None EBV, CMV, HIV, hepatitis viruses A, B, C,"/>
  <result pre="symptomatic cases High in icteric hepatitis None EBV, CMV, HIV," exact="hepatitis" post="viruses A, B, C, D, E, arboviruses (yellow fever,"/>
  <result pre="Coxiella burnetii, Brucella, Bartonella, Babesia, Pneumococcus, Clostridium perfringens Malarial parasites" exact="Hemorrhagic fever" post="Day 2â€&quot;14 (day 2â€&quot;4) 1â€&quot;25% of symptomatic cases 25â€&quot;65%"/>
  <result pre="Malarial parasites Hemorrhagic fever Day 2â€&quot;14 (day 2â€&quot;4) 1â€&quot;25% of" exact="symptomatic" post="cases 25â€&quot;65% None Hemorrhagic viral fevers, Leptospira spp. Ocular"/>
  <result pre="Day 2â€&quot;14 (day 2â€&quot;4) 1â€&quot;25% of symptomatic cases 25â€&quot;65% None" exact="Hemorrhagic" post="viral fevers, Leptospira spp. Ocular signs Day 4â€&quot;20 0.5â€&quot;15%"/>
  <result pre="2â€&quot;14 (day 2â€&quot;4) 1â€&quot;25% of symptomatic cases 25â€&quot;65% None Hemorrhagic" exact="viral" post="fevers, Leptospira spp. Ocular signs Day 4â€&quot;20 0.5â€&quot;15% of"/>
  <result pre="of symptomatic cases 25â€&quot;65% None Hemorrhagic viral fevers, Leptospira spp." exact="Ocular" post="signs Day 4â€&quot;20 0.5â€&quot;15% of symptomatic cases â€&quot; Reduced"/>
  <result pre="viral fevers, Leptospira spp. Ocular signs Day 4â€&quot;20 0.5â€&quot;15% of" exact="symptomatic" post="cases â€&quot; Reduced or lost vision Measles, rubella, influenza,"/>
  <result pre="spp. Ocular signs Day 4â€&quot;20 0.5â€&quot;15% of symptomatic cases â€&quot;" exact="Reduced" post="or lost vision Measles, rubella, influenza, CMV, HSV, VZV,"/>
  <result pre="influenza, CMV, HSV, VZV, West Nile, chikungunya, dengue and various" exact="encephalitis" post="viruses Rickettsia spp., Borrelia burgdorferi, Treponema pallidum Acute encephalitis"/>
  <result pre="West Nile, chikungunya, dengue and various encephalitis viruses Rickettsia spp.," exact="Borrelia" post="burgdorferi, Treponema pallidum Acute encephalitis Day 2â€&quot;10 50% Neurologic"/>
  <result pre="and various encephalitis viruses Rickettsia spp., Borrelia burgdorferi, Treponema pallidum" exact="Acute" post="encephalitis Day 2â€&quot;10 50% Neurologic disorders Enteroviruses, measles, mumps,"/>
  <result pre="various encephalitis viruses Rickettsia spp., Borrelia burgdorferi, Treponema pallidum Acute" exact="encephalitis" post="Day 2â€&quot;10 50% Neurologic disorders Enteroviruses, measles, mumps, rubella,"/>
  <result pre="spp., Borrelia burgdorferi, Treponema pallidum Acute encephalitis Day 2â€&quot;10 50%" exact="Neurologic" post="disorders Enteroviruses, measles, mumps, rubella, influenza, rabies viruses, arboviruses"/>
  <result pre="Day 2â€&quot;10 50% Neurologic disorders Enteroviruses, measles, mumps, rubella, influenza," exact="rabies" post="viruses, arboviruses (West-Nile, dengue, regional encephalitis), HIV Listeria, Rickettsia,"/>
  <result pre="Rickettsia, Treponema pallidum, Brucella, Borrelia, Leptospirosa spp., Chlamydia, Mycoplasma, Â±bacterial" exact="meningitis" post="(meningococcal, pneumococcal) Plasmodium falciparum, Trypanosoma spp., Toxoplasma gondii, Echinococcus,"/>
  <result pre="Plasmodium falciparum, Trypanosoma spp., Toxoplasma gondii, Echinococcus, Cryptococcus, Histoplasma capsulatum" exact="Delayed" post="encephalitis Day 4â€&quot; 60 1â€&quot;5% of symptomatic cases Neurologic"/>
  <result pre="falciparum, Trypanosoma spp., Toxoplasma gondii, Echinococcus, Cryptococcus, Histoplasma capsulatum Delayed" exact="encephalitis" post="Day 4â€&quot; 60 1â€&quot;5% of symptomatic cases Neurologic disorders"/>
  <result pre="Cryptococcus, Histoplasma capsulatum Delayed encephalitis Day 4â€&quot; 60 1â€&quot;5% of" exact="symptomatic" post="cases Neurologic disorders HIV human immunodeficiency virus, EBV Epstein"/>
  <result pre="capsulatum Delayed encephalitis Day 4â€&quot; 60 1â€&quot;5% of symptomatic cases" exact="Neurologic" post="disorders HIV human immunodeficiency virus, EBV Epstein Barr virus,"/>
  <result pre="4â€&quot; 60 1â€&quot;5% of symptomatic cases Neurologic disorders HIV human" exact="immunodeficiency" post="virus, EBV Epstein Barr virus, CMV cytomegalovirus, HSV herpes"/>
  <result pre="human immunodeficiency virus, EBV Epstein Barr virus, CMV cytomegalovirus, HSV" exact="herpes" post="simplex viruses, VZV varicella zoster virus Risk factors for"/>
  <result pre="Barr virus, CMV cytomegalovirus, HSV herpes simplex viruses, VZV varicella" exact="zoster" post="virus Risk factors for severe disease Determinants for severe"/>
  <result pre="simplex viruses, VZV varicella zoster virus Risk factors for severe" exact="disease" post="Determinants for severe RVF outcome are poorly known. A"/>
  <result pre="animal products are factors associated with increased likelihood of RVF" exact="virus infection" post="and possibly more severe outcomes [19, 53]. This is"/>
  <result pre="products are factors associated with increased likelihood of RVF virus" exact="infection" post="and possibly more severe outcomes [19, 53]. This is"/>
  <result pre="MAVS, and RIG-I) were also associated with severe symptomatology [55]." exact="Acute" post="malaria co-occurrence was observed in severe forms and HIV-positive"/>
  <result pre="and RIG-I) were also associated with severe symptomatology [55]. Acute" exact="malaria" post="co-occurrence was observed in severe forms and HIV-positive status"/>
  <result pre="[55]. Acute malaria co-occurrence was observed in severe forms and" exact="HIV-positive" post="status was associated with a 75% case fatality rate"/>
  <result pre="rate in Tanzania in 2007 [19]. Schistosomal liver co-involvement and" exact="bacterial" post="or fungal co-infections were also documented in fatal cases"/>
  <result pre="or fungal co-infections were also documented in fatal cases [37]." exact="Hepatic" post="manifestations Liver is the primary site of RVFV replication,"/>
  <result pre="documented in fatal cases [37]. Hepatic manifestations Liver is the" exact="primary" post="site of RVFV replication, so that it is frequently"/>
  <result pre="replication, so that it is frequently early involved during RVFV" exact="acute" post="infection [56, 57]. A severe acute hepatotropic disease may"/>
  <result pre="so that it is frequently early involved during RVFV acute" exact="infection" post="[56, 57]. A severe acute hepatotropic disease may occur"/>
  <result pre="early involved during RVFV acute infection [56, 57]. A severe" exact="acute" post="hepatotropic disease may occur with liver failure and jaundice"/>
  <result pre="during RVFV acute infection [56, 57]. A severe acute hepatotropic" exact="disease" post="may occur with liver failure and jaundice within the"/>
  <result pre="[56, 57]. A severe acute hepatotropic disease may occur with" exact="liver failure" post="and jaundice within the first 3Â weeks of the"/>
  <result pre="failure and jaundice within the first 3Â weeks of the" exact="disease" post="[43]. Tenderness, palpable enlargement and more than threefold elevation"/>
  <result pre="to be independently associated with a high mortality rate [40]." exact="Acute" post="hepatitis may complicate with prolonged blood coagulation times and"/>
  <result pre="be independently associated with a high mortality rate [40]. Acute" exact="hepatitis" post="may complicate with prolonged blood coagulation times and may"/>
  <result pre="Autopsy studies and pathogenesis characterization in mouse model found evidence" exact="of liver" post="necrosis with RVF viral antigens identified within hepatocytes and"/>
  <result pre="in mouse model found evidence of liver necrosis with RVF" exact="viral" post="antigens identified within hepatocytes and KÃ¼pffer cells, arguing for"/>
  <result pre="59, 60]. A RVF case with a co-existing condition of" exact="cirrhosis" post="after hepatitis B infection died as a result of"/>
  <result pre="A RVF case with a co-existing condition of cirrhosis after" exact="hepatitis" post="B infection died as a result of gastrointestinal bleeding"/>
  <result pre="case with a co-existing condition of cirrhosis after hepatitis B" exact="infection" post="died as a result of gastrointestinal bleeding and hepatic"/>
  <result pre="after hepatitis B infection died as a result of gastrointestinal" exact="bleeding" post="and hepatic encephalitis in Mayotte [28], and 4/31 (13%)"/>
  <result pre="infection died as a result of gastrointestinal bleeding and hepatic" exact="encephalitis" post="in Mayotte [28], and 4/31 (13%) severe cases described"/>
  <result pre="cases described during the epidemic in Mauritania in 2015 had" exact="chronic hepatitis" post="B [61], suggesting that patients with chronic hepatic disordersâ€&quot;mainly"/>
  <result pre="described during the epidemic in Mauritania in 2015 had chronic" exact="hepatitis" post="B [61], suggesting that patients with chronic hepatic disordersâ€&quot;mainly"/>
  <result pre="2015 had chronic hepatitis B [61], suggesting that patients with" exact="chronic" post="hepatic disordersâ€&quot;mainly hepatitis B chronic infectionâ€&quot;could be at higher"/>
  <result pre="hepatitis B [61], suggesting that patients with chronic hepatic disordersâ€&quot;mainly" exact="hepatitis" post="B chronic infectionâ€&quot;could be at higher risk of unfavorable"/>
  <result pre="[61], suggesting that patients with chronic hepatic disordersâ€&quot;mainly hepatitis B" exact="chronic" post="infectionâ€&quot;could be at higher risk of unfavorable outcome. Hemorrhagic"/>
  <result pre="B chronic infectionâ€&quot;could be at higher risk of unfavorable outcome." exact="Hemorrhagic fever" post="Soon after the onset of flu-like illness or acute"/>
  <result pre="Hemorrhagic fever Soon after the onset of flu-like illness or" exact="acute" post="hepatitis, patients may present bleeding from the nose or"/>
  <result pre="onset of flu-like illness or acute hepatitis, patients may present" exact="bleeding" post="from the nose or gums (gingivorrhagia being a key"/>
  <result pre="hematemesis or melaena, petechial/purpuric rash or ecchymoses, menorrhagia, hematuria, or" exact="bleeding" post="from venipuncture sites [46, 63]. Yellow fever-like expression were"/>
  <result pre="reliable sign of how serious the illness is [64, 65]." exact="Thrombocytopenia" post="is invariably present. Hepato-renal failure with jaundice, disseminated intravascular"/>
  <result pre="[64, 65]. Thrombocytopenia is invariably present. Hepato-renal failure with jaundice," exact="disseminated intravascular coagulation" post="and encephalitis can be associated [44, 66]. Overall prevalence"/>
  <result pre="invariably present. Hepato-renal failure with jaundice, disseminated intravascular coagulation and" exact="encephalitis" post="can be associated [44, 66]. Overall prevalence is estimated"/>
  <result pre="2007 outbreak in Kenya even reported 26% of hemorrhagic RVF" exact="disease" post="with a mortality of 23% in this group of"/>
  <result pre="this group of cases [67]. Indeed, the mortality rate associated" exact="with bleeding" post="manifestations is the highest, up to 65% [40, 68]."/>
  <result pre="group of cases [67]. Indeed, the mortality rate associated with" exact="bleeding" post="manifestations is the highest, up to 65% [40, 68]."/>
  <result pre="bleeding manifestations is the highest, up to 65% [40, 68]." exact="Viral" post="load could play an important role in the hemorrhagic"/>
  <result pre="associated with coagulation pathways occurring on the endothelial surface [69]." exact="Meningoencephalitis" post="The onset of meningoencephalitis usually occurs 1 to 4Â"/>
  <result pre="occurring on the endothelial surface [69]. Meningoencephalitis The onset of" exact="meningoencephalitis" post="usually occurs 1 to 4Â weeks after the first"/>
  <result pre="memory, hallucinations, confusion, disorientation, vertigo, convulsions, ataxia, lethargy, decerebrate posturing," exact="locked-in syndrome" post="and coma [17, 35, 44, 70â€&quot;73]. In a human"/>
  <result pre="hallucinations, confusion, disorientation, vertigo, convulsions, ataxia, lethargy, decerebrate posturing, locked-in" exact="syndrome" post="and coma [17, 35, 44, 70â€&quot;73]. In a human"/>
  <result pre="outbreak in Mauritania in 1989, up to 5% of observed" exact="infections" post="had encephalitis [71]. Two types of pure encephalitis were"/>
  <result pre="Mauritania in 1989, up to 5% of observed infections had" exact="encephalitis" post="[71]. Two types of pure encephalitis were described: acute"/>
  <result pre="of observed infections had encephalitis [71]. Two types of pure" exact="encephalitis" post="were described: acute febrile forms with short duration and"/>
  <result pre="had encephalitis [71]. Two types of pure encephalitis were described:" exact="acute" post="febrile forms with short duration and possibility of death,"/>
  <result pre="types of pure encephalitis were described: acute febrile forms with" exact="short" post="duration and possibility of death, and subacute forms with"/>
  <result pre="febrile forms with short duration and possibility of death, and" exact="subacute" post="forms with a longer duration, a lower fatality rate"/>
  <result pre="of death, and subacute forms with a longer duration, a" exact="lower" post="fatality rate but frequent sequelae [71]. Pulmonary complications may"/>
  <result pre="longer duration, a lower fatality rate but frequent sequelae [71]." exact="Pulmonary" post="complications may occur [71, 74], and malaria can worsen"/>
  <result pre="frequent sequelae [71]. Pulmonary complications may occur [71, 74], and" exact="malaria" post="can worsen the severity of neurologic symptoms [19]. Lethality"/>
  <result pre="clear a cellular CSF were documented in all cases with" exact="encephalitis" post="[71]. In a 18-year old woman treated for chronic"/>
  <result pre="with encephalitis [71]. In a 18-year old woman treated for" exact="chronic" post="myeloid leukemia with acute RVFV encephalitis acquired in Saudi"/>
  <result pre="encephalitis [71]. In a 18-year old woman treated for chronic" exact="myeloid leukemia" post="with acute RVFV encephalitis acquired in Saudi Arabia, CSF"/>
  <result pre="[71]. In a 18-year old woman treated for chronic myeloid" exact="leukemia" post="with acute RVFV encephalitis acquired in Saudi Arabia, CSF"/>
  <result pre="a 18-year old woman treated for chronic myeloid leukemia with" exact="acute" post="RVFV encephalitis acquired in Saudi Arabia, CSF was documented"/>
  <result pre="old woman treated for chronic myeloid leukemia with acute RVFV" exact="encephalitis" post="acquired in Saudi Arabia, CSF was documented predominantly with"/>
  <result pre="woman treated for chronic myeloid leukemia with acute RVFV encephalitis" exact="acquired" post="in Saudi Arabia, CSF was documented predominantly with polynuclear"/>
  <result pre="on T2-weighted images in frontoparietal and thalamic regions, with multiple" exact="bilateral" post="asymmetrical cortical hyperintense areas consistent with inflammation or ischemia"/>
  <result pre="images in frontoparietal and thalamic regions, with multiple bilateral asymmetrical" exact="cortical" post="hyperintense areas consistent with inflammation or ischemia in axial"/>
  <result pre="multiple bilateral asymmetrical cortical hyperintense areas consistent with inflammation or" exact="ischemia" post="in axial diffusion, while changes in CT-scan of her"/>
  <result pre="ischemia in axial diffusion, while changes in CT-scan of her" exact="brain" post="appeared much later [70]. In delayed meningoencephalitis normal glucose"/>
  <result pre="CT-scan of her brain appeared much later [70]. In delayed" exact="meningoencephalitis" post="normal glucose and protein concentrations will lymphocytic pleocytosis were"/>
  <result pre="in CSF [17]. In a kidney transplant recipient with cured" exact="hepatitis" post="B, presenting acute hepatitis followed by delayed pachymeningitis, specific"/>
  <result pre="In a kidney transplant recipient with cured hepatitis B, presenting" exact="acute" post="hepatitis followed by delayed pachymeningitis, specific RVF-IgM were detected"/>
  <result pre="a kidney transplant recipient with cured hepatitis B, presenting acute" exact="hepatitis" post="followed by delayed pachymeningitis, specific RVF-IgM were detected in"/>
  <result pre="In a mouse model of RVF infection, survivors to primarily" exact="hepatitis" post="cleared the virus from liver and blood, but exhibited"/>
  <result pre="virus from liver and blood, but exhibited neuro-invasion and fatal" exact="encephalitis" post="[57]. Active viral replication in brain leading to necrotizing"/>
  <result pre="and blood, but exhibited neuro-invasion and fatal encephalitis [57]. Active" exact="viral" post="replication in brain leading to necrotizing encephalitis was documented"/>
  <result pre="exhibited neuro-invasion and fatal encephalitis [57]. Active viral replication in" exact="brain" post="leading to necrotizing encephalitis was documented in several animal"/>
  <result pre="encephalitis [57]. Active viral replication in brain leading to necrotizing" exact="encephalitis" post="was documented in several animal models [75, 76]. The"/>
  <result pre="immune response could be a determining factor of the RVF" exact="neurologic disease" post="course [77]. Indeed, whatever the routes of inoculation, RVFV"/>
  <result pre="response could be a determining factor of the RVF neurologic" exact="disease" post="course [77]. Indeed, whatever the routes of inoculation, RVFV"/>
  <result pre="the routes of inoculation, RVFV RNA was detected in the" exact="brain" post="of infected rats confirming the virus neurotropism [78], but"/>
  <result pre="and more severe neuropathology in the murine model and fatal" exact="encephalitis" post="in primates [75, 76]. In aerosol-infected rats with lethal"/>
  <result pre="lethal encephalitis, neutrophils and macrophages were the major cell types" exact="infiltrating" post="the CNS, and this was concomitant with microglia activation"/>
  <result pre="microglia activation and extensive cytokine inflammation [78]. Differences in the" exact="peripheral" post="blood biomarkers during the course of the neurological disease"/>
  <result pre="in the peripheral blood biomarkers during the course of the" exact="neurological disease" post="in African green monkeys were measured with defect in"/>
  <result pre="the peripheral blood biomarkers during the course of the neurological" exact="disease" post="in African green monkeys were measured with defect in"/>
  <result pre="blood biomarkers during the course of the neurological disease in" exact="African" post="green monkeys were measured with defect in early T-cells,"/>
  <result pre="defect in early T-cells, proinflammatory and antiviral responses in lethal" exact="encephalitis" post="[79]. Other immune disorders and alteration in vascular permeability"/>
  <result pre="T-cells, proinflammatory and antiviral responses in lethal encephalitis [79]. Other" exact="immune disorders" post="and alteration in vascular permeability in the brain could"/>
  <result pre="in lethal encephalitis [79]. Other immune disorders and alteration in" exact="vascular" post="permeability in the brain could be more involved in"/>
  <result pre="Other immune disorders and alteration in vascular permeability in the" exact="brain" post="could be more involved in delayed forms [80]. Other"/>
  <result pre="During RVFV infection, elevated urea and creatinine levels may be" exact="secondary" post="to hypovolemia, multiple-organ dysfunction, or hepatorenal syndrome [39, 81]."/>
  <result pre="creatinine levels may be secondary to hypovolemia, multiple-organ dysfunction, or" exact="hepatorenal syndrome" post="[39, 81]. Acute hepatonephritis, possibly related to direct RVFV"/>
  <result pre="levels may be secondary to hypovolemia, multiple-organ dysfunction, or hepatorenal" exact="syndrome" post="[39, 81]. Acute hepatonephritis, possibly related to direct RVFV"/>
  <result pre="secondary to hypovolemia, multiple-organ dysfunction, or hepatorenal syndrome [39, 81]." exact="Acute" post="hepatonephritis, possibly related to direct RVFV injury, characterized by"/>
  <result pre="In Mauritania in 2015, creatininemia was meanly more than fourfold" exact="upper" post="the reference range in severe cases [61]. In Saudi"/>
  <result pre="them [81]. The mortality rate was 31% in patients with" exact="acute" post="renal failure, 25% in those with hepatorenal syndrome, and"/>
  <result pre="[81]. The mortality rate was 31% in patients with acute" exact="renal failure," post="25% in those with hepatorenal syndrome, and 31% in"/>
  <result pre="in patients with acute renal failure, 25% in those with" exact="hepatorenal syndrome," post="and 31% in patients with primary hepatic involvement and"/>
  <result pre="in those with hepatorenal syndrome, and 31% in patients with" exact="primary" post="hepatic involvement and mild renal impairment [81]. Progression to"/>
  <result pre="primary hepatic involvement and mild renal impairment [81]. Progression to" exact="chronic" post="renal failure was not seen [40, 47, 81]. In"/>
  <result pre="hepatic involvement and mild renal impairment [81]. Progression to chronic" exact="renal failure" post="was not seen [40, 47, 81]. In 2008 in"/>
  <result pre="not seen [40, 47, 81]. In 2008 in Mayotte, an" exact="acute" post="pericarditis with symptoms of right-sided heart failure, relapsing at"/>
  <result pre="seen [40, 47, 81]. In 2008 in Mayotte, an acute" exact="pericarditis" post="with symptoms of right-sided heart failure, relapsing at 1Â"/>
  <result pre="2008 in Mayotte, an acute pericarditis with symptoms of right-sided" exact="heart" post="failure, relapsing at 1Â month, was documented in a"/>
  <result pre="was documented in a 53-year old farmer diagnosed with RVFV" exact="infection" post="[28]. In historical post-mortem examinations, fragmentation in myocardial muscle"/>
  <result pre="RVFV infection [28]. In historical post-mortem examinations, fragmentation in myocardial" exact="muscle" post="was found in two cases and RVFV was isolated"/>
  <result pre="and RVFV was isolated from one pericardial fluid [37, 44]." exact="Ocular" post="complications Macular exudates with potential permanent loss of central"/>
  <result pre="was isolated from one pericardial fluid [37, 44]. Ocular complications" exact="Macular" post="exudates with potential permanent loss of central visual acuity"/>
  <result pre="Ocular complications Macular exudates with potential permanent loss of central" exact="visual" post="acuity were firstly described in 7 among 20,000 estimated"/>
  <result pre="among 20,000 estimated cases ( 82, 83]. The prevalence of" exact="ocular" post="manifestations has been estimated to 1% during epidemic outbreaks"/>
  <result pre="to 15% both in patients with mild and severe RVF" exact="disease" post="during the 2000 outbreak in southwest Saudi Arabia [84]."/>
  <result pre="disease during the 2000 outbreak in southwest Saudi Arabia [84]." exact="Unilateral" post="or bilateral symptoms generally occur 5 to 14Â days"/>
  <result pre="the 2000 outbreak in southwest Saudi Arabia [84]. Unilateral or" exact="bilateral" post="symptoms generally occur 5 to 14Â days after the"/>
  <result pre="infection, but can be more delayed, and may include decreased" exact="visual" post="acuity, scotoma, acute hemorrhagic conjunctivitis and retro-orbital pain [85]."/>
  <result pre="be more delayed, and may include decreased visual acuity, scotoma," exact="acute" post="hemorrhagic conjunctivitis and retro-orbital pain [85]. The most frequent"/>
  <result pre="delayed, and may include decreased visual acuity, scotoma, acute hemorrhagic" exact="conjunctivitis" post="and retro-orbital pain [85]. The most frequent and most"/>
  <result pre="and retro-orbital pain [85]. The most frequent and most specific" exact="ocular" post="lesion is a macular or paramacular retinitis [86, 87]."/>
  <result pre="and most specific ocular lesion is a macular or paramacular" exact="retinitis" post="[86, 87]. The funduscopy by indirect ophthalmoscopy usually shows"/>
  <result pre="demarcated necrotic lesion with ill-defined creamy-white patchy lesions of macular" exact="retinitis" post="with hemorrhages [84]. The other retinal signs include arterial"/>
  <result pre="with hemorrhages [84]. The other retinal signs include arterial occlusions," exact="vasculitis" post="(mostly phlebitis and sometimes arteritis) [84], sheathing of the"/>
  <result pre="[84]. The other retinal signs include arterial occlusions, vasculitis (mostly" exact="phlebitis" post="and sometimes arteritis) [84], sheathing of the vessels, which"/>
  <result pre="described in 15% of cases with retinal involvement, and no" exact="infectious" post="optic neuropathy was reported [84, 85]. Anterior uveitis was"/>
  <result pre="in 15% of cases with retinal involvement, and no infectious" exact="optic neuropathy" post="was reported [84, 85]. Anterior uveitis was associated with"/>
  <result pre="15% of cases with retinal involvement, and no infectious optic" exact="neuropathy" post="was reported [84, 85]. Anterior uveitis was associated with"/>
  <result pre="involvement, and no infectious optic neuropathy was reported [84, 85]." exact="Anterior" post="uveitis was associated with a posterior uveitis, defining a"/>
  <result pre="and no infectious optic neuropathy was reported [84, 85]. Anterior" exact="uveitis" post="was associated with a posterior uveitis, defining a panuveitis"/>
  <result pre="was reported [84, 85]. Anterior uveitis was associated with a" exact="posterior uveitis," post="defining a panuveitis with aqueous flare and fine non-granulomatous"/>
  <result pre="Anterior uveitis was associated with a posterior uveitis, defining a" exact="panuveitis" post="with aqueous flare and fine non-granulomatous keratic precipitates [84,"/>
  <result pre="85]. Fluorescein angiography performed during the active phase of the" exact="disease" post="may show early hypofluorescence with delayed filling of the"/>
  <result pre="the diagnosis of vasculitis, showing vessels sheathing and staining, and" exact="vascular" post="occlusions when present. Follow-up fluorescein angiography performed several months"/>
  <result pre="have revealed window defect in the area of the retinitis," exact="vascular" post="occlusions and obliterated macular vessels [84]. However, ophthalmoscopic and"/>
  <result pre="[84]. However, ophthalmoscopic and angiographic features of the RVFV associated" exact="retinitis" post="are not specific and can be encountered in several"/>
  <result pre="retinitis are not specific and can be encountered in several" exact="viral" post="or bacterial infections (TableÂ 3) [85, 87â€&quot;89]. TableÂ 3"/>
  <result pre="not specific and can be encountered in several viral or" exact="bacterial infections" post="(TableÂ 3) [85, 87â€&quot;89]. TableÂ 3 Main alternative infectious"/>
  <result pre="specific and can be encountered in several viral or bacterial" exact="infections" post="(TableÂ 3) [85, 87â€&quot;89]. TableÂ 3 Main alternative infectious"/>
  <result pre="bacterial infections (TableÂ 3) [85, 87â€&quot;89]. TableÂ 3 Main alternative" exact="infectious" post="diagnoses for RVFV retinitis and their characteristics Retinal lesions"/>
  <result pre="[85, 87â€&quot;89]. TableÂ 3 Main alternative infectious diagnoses for RVFV" exact="retinitis" post="and their characteristics Retinal lesions Absent lesions Localisation Vitreous"/>
  <result pre="Main alternative infectious diagnoses for RVFV retinitis and their characteristics" exact="Retinal" post="lesions Absent lesions Localisation Vitreous lesions Anterior lesions Keratic"/>
  <result pre="RVFV retinitis and their characteristics Retinal lesions Absent lesions Localisation" exact="Vitreous" post="lesions Anterior lesions Keratic lesions Onset Specific treatment Measles"/>
  <result pre="and their characteristics Retinal lesions Absent lesions Localisation Vitreous lesions" exact="Anterior" post="lesions Keratic lesions Onset Specific treatment Measles virus Diffuse"/>
  <result pre="lesions Anterior lesions Keratic lesions Onset Specific treatment Measles virus" exact="Diffuse" post="retinal edema, small hemorrhages, exudative stellate macular lesions, attenuate"/>
  <result pre="Anterior lesions Keratic lesions Onset Specific treatment Measles virus Diffuse" exact="retinal edema," post="small hemorrhages, exudative stellate macular lesions, attenuate vessels, optic"/>
  <result pre="Onset Specific treatment Measles virus Diffuse retinal edema, small hemorrhages," exact="exudative" post="stellate macular lesions, attenuate vessels, optic disc edema Retinal"/>
  <result pre="hemorrhages, exudative stellate macular lesions, attenuate vessels, optic disc edema" exact="Retinal" post="necrotic lesions Diffuse No No Punctuate epithelial erosions and"/>
  <result pre="macular lesions, attenuate vessels, optic disc edema Retinal necrotic lesions" exact="Diffuse" post="No No Punctuate epithelial erosions and keratitis Few days"/>
  <result pre="optic disc edema Retinal necrotic lesions Diffuse No No Punctuate" exact="epithelial" post="erosions and keratitis Few days after the skin rash"/>
  <result pre="Retinal necrotic lesions Diffuse No No Punctuate epithelial erosions and" exact="keratitis" post="Few days after the skin rash or later with"/>
  <result pre="SSPE No Rubella virus Chorioretinitis, RPE detachment, bullous retinal detachment" exact="Retinal" post="hemorrhages, vasculitis, optic disc edema Posterior pole Mild vitreous"/>
  <result pre="vasculitis, optic disc edema Posterior pole Mild vitreous reaction Mild" exact="anterior uveitis" post="Central epithelial keratitis â€&quot; Topical or oral corticosteroids on"/>
  <result pre="optic disc edema Posterior pole Mild vitreous reaction Mild anterior" exact="uveitis" post="Central epithelial keratitis â€&quot; Topical or oral corticosteroids on"/>
  <result pre="disc edema Posterior pole Mild vitreous reaction Mild anterior uveitis" exact="Central" post="epithelial keratitis â€&quot; Topical or oral corticosteroids on bullous"/>
  <result pre="edema Posterior pole Mild vitreous reaction Mild anterior uveitis Central" exact="epithelial" post="keratitis â€&quot; Topical or oral corticosteroids on bullous retinal"/>
  <result pre="Posterior pole Mild vitreous reaction Mild anterior uveitis Central epithelial" exact="keratitis" post="â€&quot; Topical or oral corticosteroids on bullous retinal detachment"/>
  <result pre="Topical or oral corticosteroids on bullous retinal detachment Influenza virus" exact="Retinal edema," post="shiny vesicular dots at the termination of a capillary,"/>
  <result pre="vesicular dots at the termination of a capillary, small hemorrhages," exact="serous" post="retinal detachment, frosted branch angiitis, neuroretinitis, optic neuritis, uveal"/>
  <result pre="capillary, small hemorrhages, serous retinal detachment, frosted branch angiitis, neuroretinitis," exact="optic neuritis," post="uveal effusion Retinal necrotic lesions Macular No Iridocyclitis Interstitial"/>
  <result pre="retinal detachment, frosted branch angiitis, neuroretinitis, optic neuritis, uveal effusion" exact="Retinal" post="necrotic lesions Macular No Iridocyclitis Interstitial keratitis, marginal corneal"/>
  <result pre="branch angiitis, neuroretinitis, optic neuritis, uveal effusion Retinal necrotic lesions" exact="Macular" post="No Iridocyclitis Interstitial keratitis, marginal corneal ulcers â€&quot; Oral"/>
  <result pre="neuroretinitis, optic neuritis, uveal effusion Retinal necrotic lesions Macular No" exact="Iridocyclitis" post="Interstitial keratitis, marginal corneal ulcers â€&quot; Oral corticosteroids for"/>
  <result pre="optic neuritis, uveal effusion Retinal necrotic lesions Macular No Iridocyclitis" exact="Interstitial" post="keratitis, marginal corneal ulcers â€&quot; Oral corticosteroids for serous"/>
  <result pre="Iridocyclitis Interstitial keratitis, marginal corneal ulcers â€&quot; Oral corticosteroids for" exact="serous" post="retinal detachment, macular edema and frosted branch angiitis Borrelia"/>
  <result pre="for serous retinal detachment, macular edema and frosted branch angiitis" exact="Borrelia" post="burgdorferi Multifocal choroiditis, vasculitis, neuroretinitis, optic disc edema Retinal"/>
  <result pre="angiitis Borrelia burgdorferi Multifocal choroiditis, vasculitis, neuroretinitis, optic disc edema" exact="Retinal" post="necrotic lesions Diffuse Posterior pole if neuroretinitis Vitritis Granulomatous"/>
  <result pre="Multifocal choroiditis, vasculitis, neuroretinitis, optic disc edema Retinal necrotic lesions" exact="Diffuse" post="Posterior pole if neuroretinitis Vitritis Granulomatous or non-granulomatous anterior"/>
  <result pre="optic disc edema Retinal necrotic lesions Diffuse Posterior pole if" exact="neuroretinitis" post="Vitritis Granulomatous or non-granulomatous anterior uveitis Stromal keratitis Several"/>
  <result pre="edema Retinal necrotic lesions Diffuse Posterior pole if neuroretinitis Vitritis" exact="Granulomatous" post="or non-granulomatous anterior uveitis Stromal keratitis Several weeks after"/>
  <result pre="lesions Diffuse Posterior pole if neuroretinitis Vitritis Granulomatous or non-granulomatous" exact="anterior uveitis" post="Stromal keratitis Several weeks after inoculation Ceftriaxone Doxycycline Topical"/>
  <result pre="Diffuse Posterior pole if neuroretinitis Vitritis Granulomatous or non-granulomatous anterior" exact="uveitis" post="Stromal keratitis Several weeks after inoculation Ceftriaxone Doxycycline Topical"/>
  <result pre="pole if neuroretinitis Vitritis Granulomatous or non-granulomatous anterior uveitis Stromal" exact="keratitis" post="Several weeks after inoculation Ceftriaxone Doxycycline Topical or systemic"/>
  <result pre="Stromal keratitis Several weeks after inoculation Ceftriaxone Doxycycline Topical or" exact="systemic" post="corticosteroids Rickettsia spp. White retinal lesions adjacent to retinal"/>
  <result pre="corticosteroids Rickettsia spp. White retinal lesions adjacent to retinal vessels," exact="serous" post="retinal detachment, retinal sheathing, hemorrhages, vascular leakage or occlusions,"/>
  <result pre="adjacent to retinal vessels, serous retinal detachment, retinal sheathing, hemorrhages," exact="vascular" post="leakage or occlusions, optic disc edema, neuroretinitis, optic neuritis,"/>
  <result pre="sheathing, hemorrhages, vascular leakage or occlusions, optic disc edema, neuroretinitis," exact="optic neuritis," post="choroidal involvement Retinal scarring Adjacent to retinal vessels Mild"/>
  <result pre="or occlusions, optic disc edema, neuroretinitis, optic neuritis, choroidal involvement" exact="Retinal" post="scarring Adjacent to retinal vessels Mild to moderate vitreous"/>
  <result pre="vessels Mild to moderate vitreous reaction No No â€&quot; Doxycycline" exact="Systemic" post="corticosteroids Dengue virus Maculopathy with macular edema, focal chorioretinitis,"/>
  <result pre="to moderate vitreous reaction No No â€&quot; Doxycycline Systemic corticosteroids" exact="Dengue" post="virus Maculopathy with macular edema, focal chorioretinitis, yellow subretinal"/>
  <result pre="vitreous reaction No No â€&quot; Doxycycline Systemic corticosteroids Dengue virus" exact="Maculopathy" post="with macular edema, focal chorioretinitis, yellow subretinal dots, foveolitis,"/>
  <result pre="â€&quot; Doxycycline Systemic corticosteroids Dengue virus Maculopathy with macular edema," exact="focal chorioretinitis," post="yellow subretinal dots, foveolitis, hemorrhages, venular sheathing, disc edema,"/>
  <result pre="chorioretinitis, yellow subretinal dots, foveolitis, hemorrhages, venular sheathing, disc edema," exact="vascular" post="occlusion, exudative retinal detachment due to vascular leakage â€&quot;"/>
  <result pre="subretinal dots, foveolitis, hemorrhages, venular sheathing, disc edema, vascular occlusion," exact="exudative" post="retinal detachment due to vascular leakage â€&quot; Macular Vitreous"/>
  <result pre="sheathing, disc edema, vascular occlusion, exudative retinal detachment due to" exact="vascular" post="leakage â€&quot; Macular Vitreous hemorrhages â€&quot; â€&quot; 1Â week"/>
  <result pre="vascular occlusion, exudative retinal detachment due to vascular leakage â€&quot;" exact="Macular" post="Vitreous hemorrhages â€&quot; â€&quot; 1Â week after the onset"/>
  <result pre="occlusion, exudative retinal detachment due to vascular leakage â€&quot; Macular" exact="Vitreous" post="hemorrhages â€&quot; â€&quot; 1Â week after the onset of"/>
  <result pre="virus Multifocal choroiditis, retinal whitening with retinal and macular edema," exact="central retinal artery occlusion," post="ONH edema when optic neuritis or neuroretinitis, exudative retinal"/>
  <result pre="Multifocal choroiditis, retinal whitening with retinal and macular edema, central" exact="retinal artery occlusion," post="ONH edema when optic neuritis or neuroretinitis, exudative retinal"/>
  <result pre="and macular edema, central retinal artery occlusion, ONH edema when" exact="optic neuritis" post="or neuroretinitis, exudative retinal detachment â€&quot; Posterior pole Mild"/>
  <result pre="macular edema, central retinal artery occlusion, ONH edema when optic" exact="neuritis" post="or neuroretinitis, exudative retinal detachment â€&quot; Posterior pole Mild"/>
  <result pre="retinal artery occlusion, ONH edema when optic neuritis or neuroretinitis," exact="exudative" post="retinal detachment â€&quot; Posterior pole Mild vitritis Granulomatous or"/>
  <result pre="or neuroretinitis, exudative retinal detachment â€&quot; Posterior pole Mild vitritis" exact="Granulomatous" post="or non granulomatous Anterior uveitis Keratitis 1Â month to"/>
  <result pre="detachment â€&quot; Posterior pole Mild vitritis Granulomatous or non granulomatous" exact="Anterior" post="uveitis Keratitis 1Â month to 1Â year after diagnosis"/>
  <result pre="â€&quot; Posterior pole Mild vitritis Granulomatous or non granulomatous Anterior" exact="uveitis" post="Keratitis 1Â month to 1Â year after diagnosis No"/>
  <result pre="Posterior pole Mild vitritis Granulomatous or non granulomatous Anterior uveitis" exact="Keratitis" post="1Â month to 1Â year after diagnosis No West"/>
  <result pre="chorioretinitis, linear clusters of circular deep yellowish lesions, retinal hemorrhages," exact="vascular" post="sheathing, occlusive vasculitis, optic disc edema â€&quot; Midzone, peripheral"/>
  <result pre="hemorrhages, vascular sheathing, occlusive vasculitis, optic disc edema â€&quot; Midzone," exact="peripheral" post="zone, posterior pole Along retinal nerve fibers Mild to"/>
  <result pre="sheathing, occlusive vasculitis, optic disc edema â€&quot; Midzone, peripheral zone," exact="posterior" post="pole Along retinal nerve fibers Mild to moderate vitritis"/>
  <result pre="disc edema â€&quot; Midzone, peripheral zone, posterior pole Along retinal" exact="nerve" post="fibers Mild to moderate vitritis Anterior uveitis No Early,"/>
  <result pre="posterior pole Along retinal nerve fibers Mild to moderate vitritis" exact="Anterior" post="uveitis No Early, contemporary to the fever No CMV"/>
  <result pre="pole Along retinal nerve fibers Mild to moderate vitritis Anterior" exact="uveitis" post="No Early, contemporary to the fever No CMV Yellow-white"/>
  <result pre="fever No CMV Yellow-white areas of necrotizing retinitis, retinal hemorrhages," exact="vascular" post="sheathing, frosted branch angiitis, ONH edema with hemorrhages if"/>
  <result pre="vascular sheathing, frosted branch angiitis, ONH edema with hemorrhages if" exact="optic neuritis" post="â€&quot; Perivascular distribution, central (10%) Mild vitreous reaction Mild"/>
  <result pre="sheathing, frosted branch angiitis, ONH edema with hemorrhages if optic" exact="neuritis" post="â€&quot; Perivascular distribution, central (10%) Mild vitreous reaction Mild"/>
  <result pre="neuritis â€&quot; Perivascular distribution, central (10%) Mild vitreous reaction Mild" exact="anterior uveitis" post="No â€&quot; Ganciclovir Foscarnet HSV Retinal edema, ARN syndrome,"/>
  <result pre="â€&quot; Perivascular distribution, central (10%) Mild vitreous reaction Mild anterior" exact="uveitis" post="No â€&quot; Ganciclovir Foscarnet HSV Retinal edema, ARN syndrome,"/>
  <result pre="vitreous reaction Mild anterior uveitis No â€&quot; Ganciclovir Foscarnet HSV" exact="Retinal edema," post="ARN syndrome, macular yellowish exudative plaques, flame-shaped hemorrhages, perivenous"/>
  <result pre="â€&quot; Ganciclovir Foscarnet HSV Retinal edema, ARN syndrome, macular yellowish" exact="exudative" post="plaques, flame-shaped hemorrhages, perivenous sheathing, arteriolar narrowing, disc edema,"/>
  <result pre="plaques, flame-shaped hemorrhages, perivenous sheathing, arteriolar narrowing, disc edema, PORN" exact="syndrome" post="â€&quot; Macular, diffuse Mild vitreous reaction Anterior uveitis with"/>
  <result pre="perivenous sheathing, arteriolar narrowing, disc edema, PORN syndrome â€&quot; Macular," exact="diffuse" post="Mild vitreous reaction Anterior uveitis with iris atrophy and"/>
  <result pre="disc edema, PORN syndrome â€&quot; Macular, diffuse Mild vitreous reaction" exact="Anterior" post="uveitis with iris atrophy and elevated IOP Dendritic stromal"/>
  <result pre="edema, PORN syndrome â€&quot; Macular, diffuse Mild vitreous reaction Anterior" exact="uveitis" post="with iris atrophy and elevated IOP Dendritic stromal ulcerations"/>
  <result pre="â€&quot; Macular, diffuse Mild vitreous reaction Anterior uveitis with iris" exact="atrophy" post="and elevated IOP Dendritic stromal ulcerations or disciform keratitis"/>
  <result pre="iris atrophy and elevated IOP Dendritic stromal ulcerations or disciform" exact="keratitis" post="â€&quot; Aciclovir VZV Focal chorioretinitis with exudates and necrotic"/>
  <result pre="Dendritic stromal ulcerations or disciform keratitis â€&quot; Aciclovir VZV Focal" exact="chorioretinitis" post="with exudates and necrotic lesions, occasional hemorrhages, sheathed vessels,"/>
  <result pre="chorioretinitis with exudates and necrotic lesions, occasional hemorrhages, sheathed vessels," exact="central retinal vein occlusion," post="ONH edema when optic neuritis, ARN syndrome, PORN syndrome"/>
  <result pre="with exudates and necrotic lesions, occasional hemorrhages, sheathed vessels, central" exact="retinal vein occlusion," post="ONH edema when optic neuritis, ARN syndrome, PORN syndrome"/>
  <result pre="hemorrhages, sheathed vessels, central retinal vein occlusion, ONH edema when" exact="optic neuritis," post="ARN syndrome, PORN syndrome â€&quot; Usually peripheral, possible macular"/>
  <result pre="vein occlusion, ONH edema when optic neuritis, ARN syndrome, PORN" exact="syndrome" post="â€&quot; Usually peripheral, possible macular extension Vitritis when ARN"/>
  <result pre="syndrome â€&quot; Usually peripheral, possible macular extension Vitritis when ARN" exact="syndrome" post="Anterior uveitis Punctuate epithelial keratitis â€&quot; Acyclovir Treponema pallidum"/>
  <result pre="â€&quot; Usually peripheral, possible macular extension Vitritis when ARN syndrome" exact="Anterior" post="uveitis Punctuate epithelial keratitis â€&quot; Acyclovir Treponema pallidum Multifocal"/>
  <result pre="Usually peripheral, possible macular extension Vitritis when ARN syndrome Anterior" exact="uveitis" post="Punctuate epithelial keratitis â€&quot; Acyclovir Treponema pallidum Multifocal chorioretinitis,"/>
  <result pre="possible macular extension Vitritis when ARN syndrome Anterior uveitis Punctuate" exact="epithelial" post="keratitis â€&quot; Acyclovir Treponema pallidum Multifocal chorioretinitis, ASPPC with"/>
  <result pre="macular extension Vitritis when ARN syndrome Anterior uveitis Punctuate epithelial" exact="keratitis" post="â€&quot; Acyclovir Treponema pallidum Multifocal chorioretinitis, ASPPC with large"/>
  <result pre="Multifocal chorioretinitis, ASPPC with large pale yellowish subretinal lesion, retinitis," exact="vasculitis" post="(arteritis and phlebitis which can be occlusive), exudative retinal"/>
  <result pre="with large pale yellowish subretinal lesion, retinitis, vasculitis (arteritis and" exact="phlebitis" post="which can be occlusive), exudative retinal detachment, neuroretinitis â€&quot;"/>
  <result pre="lesion, retinitis, vasculitis (arteritis and phlebitis which can be occlusive)," exact="exudative" post="retinal detachment, neuroretinitis â€&quot; Multifocal Posterior pole when ASPPC"/>
  <result pre="(arteritis and phlebitis which can be occlusive), exudative retinal detachment," exact="neuroretinitis" post="â€&quot; Multifocal Posterior pole when ASPPC Vitritis or vitreous"/>
  <result pre="Multifocal Posterior pole when ASPPC Vitritis or vitreous reaction to" exact="chorioretinitis" post="Granulomatous or non- granulomatous anterior uveitis bilateral in 50%"/>
  <result pre="Posterior pole when ASPPC Vitritis or vitreous reaction to chorioretinitis" exact="Granulomatous" post="or non- granulomatous anterior uveitis bilateral in 50% Stromal"/>
  <result pre="Vitritis or vitreous reaction to chorioretinitis Granulomatous or non- granulomatous" exact="anterior uveitis" post="bilateral in 50% Stromal keratitis Several weeks after inoculation"/>
  <result pre="or vitreous reaction to chorioretinitis Granulomatous or non- granulomatous anterior" exact="uveitis" post="bilateral in 50% Stromal keratitis Several weeks after inoculation"/>
  <result pre="vitreous reaction to chorioretinitis Granulomatous or non- granulomatous anterior uveitis" exact="bilateral" post="in 50% Stromal keratitis Several weeks after inoculation Penicillin"/>
  <result pre="Granulomatous or non- granulomatous anterior uveitis bilateral in 50% Stromal" exact="keratitis" post="Several weeks after inoculation Penicillin G Topical or systemic"/>
  <result pre="Stromal keratitis Several weeks after inoculation Penicillin G Topical or" exact="systemic" post="corticosteroids RPE retinal pigment epithelium, ONH optic nerve hypoplasia,"/>
  <result pre="Topical or systemic corticosteroids RPE retinal pigment epithelium, ONH optic" exact="nerve" post="hypoplasia, ARN syndrome acute retinal necrosis, PORN syndrome progressive"/>
  <result pre="corticosteroids RPE retinal pigment epithelium, ONH optic nerve hypoplasia, ARN" exact="syndrome" post="acute retinal necrosis, PORN syndrome progressive outer retinal necrosis,"/>
  <result pre="RPE retinal pigment epithelium, ONH optic nerve hypoplasia, ARN syndrome" exact="acute" post="retinal necrosis, PORN syndrome progressive outer retinal necrosis, ASPPC"/>
  <result pre="ONH optic nerve hypoplasia, ARN syndrome acute retinal necrosis, PORN" exact="syndrome" post="progressive outer retinal necrosis, ASPPC acute syphilitic posterior placoid"/>
  <result pre="acute retinal necrosis, PORN syndrome progressive outer retinal necrosis, ASPPC" exact="acute" post="syphilitic posterior placoid chorioretinopathy, CMV cytomegalovirus, HSV herpes simplex"/>
  <result pre="necrosis, PORN syndrome progressive outer retinal necrosis, ASPPC acute syphilitic" exact="posterior" post="placoid chorioretinopathy, CMV cytomegalovirus, HSV herpes simplex viruses, VZV"/>
  <result pre="necrosis, ASPPC acute syphilitic posterior placoid chorioretinopathy, CMV cytomegalovirus, HSV" exact="herpes" post="simplex viruses, VZV varicella zoster virus, SSPE subacute sclerosing"/>
  <result pre="placoid chorioretinopathy, CMV cytomegalovirus, HSV herpes simplex viruses, VZV varicella" exact="zoster" post="virus, SSPE subacute sclerosing panencephalitis Ocular active lesions resolve"/>
  <result pre="cytomegalovirus, HSV herpes simplex viruses, VZV varicella zoster virus, SSPE" exact="subacute sclerosing panencephalitis" post="Ocular active lesions resolve spontaneously in 10 to 12Â"/>
  <result pre="simplex viruses, VZV varicella zoster virus, SSPE subacute sclerosing panencephalitis" exact="Ocular" post="active lesions resolve spontaneously in 10 to 12Â weeks."/>
  <result pre="Ocular active lesions resolve spontaneously in 10 to 12Â weeks." exact="Macular" post="or paramacular scarring, vascular occlusions and post-infectious optic atrophy"/>
  <result pre="spontaneously in 10 to 12Â weeks. Macular or paramacular scarring," exact="vascular" post="occlusions and post-infectious optic atrophy associated to the central"/>
  <result pre="12Â weeks. Macular or paramacular scarring, vascular occlusions and post-infectious" exact="optic atrophy" post="associated to the central scarring lead to poor visual"/>
  <result pre="weeks. Macular or paramacular scarring, vascular occlusions and post-infectious optic" exact="atrophy" post="associated to the central scarring lead to poor visual"/>
  <result pre="optic atrophy associated to the central scarring lead to poor" exact="visual" post="acuity outcomes. Retinal complications may cause 40â€&quot;50% of permanent"/>
  <result pre="to the central scarring lead to poor visual acuity outcomes." exact="Retinal" post="complications may cause 40â€&quot;50% of permanent vision loss, and"/>
  <result pre="visual acuity outcomes. Retinal complications may cause 40â€&quot;50% of permanent" exact="vision loss," post="and up to 71% of the affected eyes reached"/>
  <result pre="71% of the affected eyes reached the criteria for legal" exact="blindness" post="[38, 84, 85]. No chronic anterior uveitis, posterior synechiae,"/>
  <result pre="reached the criteria for legal blindness [38, 84, 85]. No" exact="chronic" post="anterior uveitis, posterior synechiae, iris nodules, uveitic glaucoma nor"/>
  <result pre="the criteria for legal blindness [38, 84, 85]. No chronic" exact="anterior uveitis," post="posterior synechiae, iris nodules, uveitic glaucoma nor cataract were"/>
  <result pre="for legal blindness [38, 84, 85]. No chronic anterior uveitis," exact="posterior" post="synechiae, iris nodules, uveitic glaucoma nor cataract were described"/>
  <result pre="85]. No chronic anterior uveitis, posterior synechiae, iris nodules, uveitic" exact="glaucoma" post="nor cataract were described [38, 84, 85]. It is"/>
  <result pre="chronic anterior uveitis, posterior synechiae, iris nodules, uveitic glaucoma nor" exact="cataract" post="were described [38, 84, 85]. It is not known"/>
  <result pre="described [38, 84, 85]. It is not known if the" exact="ocular" post="manifestations of the RVF result from direct toxicity of"/>
  <result pre="response to the infection. Post-mortem examination suggested the presence of" exact="focal" post="areas of retinal necrosis and retinal pigment epithelium (RPE)"/>
  <result pre="perivascular cuffing but the presence of the virus in the" exact="ocular" post="tissues has not been proved. Most of animal models"/>
  <result pre="Most of animal models for RVF do not show any" exact="ocular" post="disease [35, 57]. In a sheep model quantitative RT-PCR"/>
  <result pre="of animal models for RVF do not show any ocular" exact="disease" post="[35, 57]. In a sheep model quantitative RT-PCR (qRT-PCR)"/>
  <result pre="RVF could also be caused by antibody-related auto-immune reactions [86]." exact="Congenital" post="and neonatal infection In a seroprevalence study, mothers experiencing"/>
  <result pre="also be caused by antibody-related auto-immune reactions [86]. Congenital and" exact="neonatal infection" post="In a seroprevalence study, mothers experiencing fetal death or"/>
  <result pre="be caused by antibody-related auto-immune reactions [86]. Congenital and neonatal" exact="infection" post="In a seroprevalence study, mothers experiencing fetal death or"/>
  <result pre="Congenital and neonatal infection In a seroprevalence study, mothers experiencing" exact="fetal death" post="or miscarriage had the same RVFV antibody prevalence as"/>
  <result pre="infection In a seroprevalence study, mothers experiencing fetal death or" exact="miscarriage" post="had the same RVFV antibody prevalence as those with"/>
  <result pre="a recent cross sectional study has demonstrated an association between" exact="infection" post="with RVFV and miscarriage in Sudanese pregnant women (54%"/>
  <result pre="study has demonstrated an association between infection with RVFV and" exact="miscarriage" post="in Sudanese pregnant women (54% versus 12% of risk"/>
  <result pre="sometimes with fatal outcome in the newborn [94, 95]. Few" exact="symptomatic" post="infections were described in pregnant women [91] and children"/>
  <result pre="with fatal outcome in the newborn [94, 95]. Few symptomatic" exact="infections" post="were described in pregnant women [91] and children under"/>
  <result pre="there are differences in susceptibility between animals and humans [8]." exact="Infection" post="prevention and control (IPC) measures Importantly, hemorrhagic complications require"/>
  <result pre="and control (IPC) measures Importantly, hemorrhagic complications require high cautious" exact="infection" post="control measures, following the CDC guidance on infection control"/>
  <result pre="high cautious infection control measures, following the CDC guidance on" exact="infection" post="control precautions for hemorrhagic viral fevers (HVFs), while waiting"/>
  <result pre="following the CDC guidance on infection control precautions for hemorrhagic" exact="viral" post="fevers (HVFs), while waiting for the exclusion of other"/>
  <result pre="for the exclusion of other HVFs such as Ebola virus" exact="disease" post="or Crimean-Congo hemorrhagic fever [39, 98]. Standard precautions with"/>
  <result pre="exclusion of other HVFs such as Ebola virus disease or" exact="Crimean-Congo hemorrhagic fever" post="[39, 98]. Standard precautions with Personal Protective Equipment (PPE)"/>
  <result pre="body fluids, secretions and excretions. Considering RVF is also mosquito-borne" exact="disease" post="[56], we recommend for all-day preventive measures against vectors"/>
  <result pre="transplantation from a RVFV-infected patient. Virologic confirmation of Rift Valley" exact="Fever" post="diagnosis Collection of specimens Samples of suspected cases must"/>
  <result pre="confirmation [9]. Diagnostic testing According to WHO a confirmed RVF" exact="infection" post="relies on (i) detection of RVFV RNA by reverse"/>
  <result pre="(ii) IgM and IgG detection by enzyme-linked immunosorbent assay (ELISA)." exact="Viral" post="isolation is also an assay for laboratory confirmation of"/>
  <result pre="isolation is also an assay for laboratory confirmation of RVFV" exact="infection" post="but this assay needs to be done on BSL3"/>
  <result pre="done on BSL3 and is less sensitive than detection of" exact="viral" post="RNA by RT-PCR. Interestingly, RT-PCR for RVFV was reported"/>
  <result pre="of symptoms [9]. Prolonged and intense viremias were reported during" exact="acute" post="encephalitis and hemorrhagic fever. Thus, testing of serial patient"/>
  <result pre="symptoms [9]. Prolonged and intense viremias were reported during acute" exact="encephalitis" post="and hemorrhagic fever. Thus, testing of serial patient specimens"/>
  <result pre="have prognostic value in determining patient outcome. The decrease in" exact="viral" post="loads coincides with a rise in RVFV specific IgM"/>
  <result pre="ELISA. The presence of IgM antibodies appears as an early" exact="transient" post="response (day 4 to 60) and protective IgG antibodies"/>
  <result pre="of a recent RVF infection. In case of delayed-onset of" exact="encephalitis" post="or ocular complications, imputation to RVFV may be difficult"/>
  <result pre="recent RVF infection. In case of delayed-onset of encephalitis or" exact="ocular" post="complications, imputation to RVFV may be difficult if only"/>
  <result pre="stage. Co-infections or alternative diagnosis with parasitic, bacterial, fungal or" exact="viral" post="pathogens must be considered and treated as early as"/>
  <result pre="and treated as early as possible to improve the outcome." exact="Severe" post="patients should be treated empirically with broad spectrum antibacterial"/>
  <result pre="[104] and was successfully used to cure and prevent from" exact="Lassa fever" post="[105]. To date, its use is not indicated when"/>
  <result pre="including favipiravir T-705, 2â€²-fluoro-2â€²-deoxycytidine (2â€²-FdC), and benzavir-2 [106â€&quot;109]. Molecules targeting" exact="viral" post="components, host cellular components or pathways, such as the"/>
  <result pre="evaluated precisely. Early renal substitution therapy in patients with severe" exact="acute" post="renal failure improve the prognosis and survival [39, 56,"/>
  <result pre="precisely. Early renal substitution therapy in patients with severe acute" exact="renal failure" post="improve the prognosis and survival [39, 56, 81]. For"/>
  <result pre="preparations may maintain corneal lubrication and provide temporary comfort for" exact="ocular" post="irritation. Topical ophthalmic steroids were used in the RVFV"/>
  <result pre="[84]. Aciclovir was used in eyes lesions of other mosquito-transmitted" exact="viral" post="disease notably chikungunya, dengue and West Nile (TableÂ 2)"/>
  <result pre="Aciclovir was used in eyes lesions of other mosquito-transmitted viral" exact="disease" post="notably chikungunya, dengue and West Nile (TableÂ 2) [112]."/>
  <result pre="case of elevated intraocular pressure, antiglaucoma medications could be useful." exact="Ocular" post="surgery including cataract removal, retinal hole and detachment repair,"/>
  <result pre="intraocular pressure, antiglaucoma medications could be useful. Ocular surgery including" exact="cataract" post="removal, retinal hole and detachment repair, vitrectomy, and laser"/>
  <result pre="requiring hospitalization for medical supervision, as we already proposed for" exact="chikungunya" post="[113]. Severe illness included hemorrhagic fever, neurological disorders or"/>
  <result pre="for medical supervision, as we already proposed for chikungunya [113]." exact="Severe" post="illness included hemorrhagic fever, neurological disorders or hepatic/renal failures"/>
  <result pre="hemorrhagic fever, neurological disorders or hepatic/renal failures requiring intensive cares." exact="Ocular" post="signs were classified as complications. Ophthalmologic examination should be"/>
  <result pre="performed in all confirmed cases to detect early asymptomatic RVFV" exact="ocular" post="signs and evaluate their potential ability to predict the"/>
  <result pre="the occurrence of neuro-ophthalmologic complications. This should at least include" exact="visual" post="acuity determination, intra-ocular pressure measurement, slit-lamp biomicroscopy and funduscopy"/>
  <result pre="Indocyanine Green angiography has not been evaluated yet in FVR" exact="ocular" post="manifestation but could possibly bring arguments for a choroidal"/>
  <result pre="onset of symptoms to monitor for possible delayed neurological and/or" exact="ocular" post="complications. In the lack of adequate medical support, considering"/>
  <result pre="emergency. Fig.Â 4 Algorithm to assess and manage Rift Valley" exact="Fever" post="cases during an outbreak Conclusion Rift Valley Fever has"/>
  <result pre="Rift Valley Fever cases during an outbreak Conclusion Rift Valley" exact="Fever" post="has emerged and extended outside Africa in the 2000s,"/>
  <result pre="losses, human morbidity and mortality may be significant during epidemics." exact="Infection" post="with RVF has a wide clinical spectrum and may"/>
  <result pre="Abbreviations ADAMTS13 a disintegrin and metalloproteinase with thrombospondin motifs ARN" exact="acute" post="retinal necrosis ASPPC acute syphilitic posterior placoid chorioretinopathy BSL"/>
  <result pre="and metalloproteinase with thrombospondin motifs ARN acute retinal necrosis ASPPC" exact="acute" post="syphilitic posterior placoid chorioretinopathy BSL biosafety level CDC Center"/>
  <result pre="with thrombospondin motifs ARN acute retinal necrosis ASPPC acute syphilitic" exact="posterior" post="placoid chorioretinopathy BSL biosafety level CDC Center for Disease"/>
  <result pre="syphilitic posterior placoid chorioretinopathy BSL biosafety level CDC Center for" exact="Disease" post="Control and Prevention CI confidence interval CMV cytomegalovirus CRP"/>
  <result pre="EBV Epstein Barr virus ELISA enzyme-linked immunosorbent assay HIV human" exact="immunodeficiency" post="virus HSV herpes simplex viruses HVFs hemorrhagic viral fevers"/>
  <result pre="virus ELISA enzyme-linked immunosorbent assay HIV human immunodeficiency virus HSV" exact="herpes" post="simplex viruses HVFs hemorrhagic viral fevers Ig immunoglobulin IPC"/>
  <result pre="HIV human immunodeficiency virus HSV herpes simplex viruses HVFs hemorrhagic" exact="viral" post="fevers Ig immunoglobulin IPC infection prevention and control IP-10"/>
  <result pre="herpes simplex viruses HVFs hemorrhagic viral fevers Ig immunoglobulin IPC" exact="infection" post="prevention and control IP-10 interferon-y induced protein MAVS mitochondrial"/>
  <result pre="IP-10 interferon-y induced protein MAVS mitochondrial antiviral signaling protein MCP-2" exact="monocyte" post="chemottractant protein MRI magnetic resonance imaging MyD88 myeloid differentiation"/>
  <result pre="imaging MyD88 myeloid differentiation OCT optic coherence tomography ONH optic" exact="nerve" post="hypoplasia PPE Personal Protective Equipment PORN progressive outer retinal"/>
  <result pre="RNA ribonucleic acid RPE retinal pigment epithelium RVF Rift Valley" exact="Fever" post="RVFV Rift Valley Fever virus sICAM-1 soluble intracellular adhesion"/>
  <result pre="retinal pigment epithelium RVF Rift Valley Fever RVFV Rift Valley" exact="Fever" post="virus sICAM-1 soluble intracellular adhesion molecule SSPE subacute sclerosing"/>
  <result pre="Rift Valley Fever virus sICAM-1 soluble intracellular adhesion molecule SSPE" exact="subacute sclerosing panencephalitis" post="TLR8 toll-like receptor tPA tissue plasminogen activator TRIF TIR-domain-containing"/>
  <result pre="tPA tissue plasminogen activator TRIF TIR-domain-containing adapter-inducing interferon-ÃŸ VZV varicella" exact="zoster" post="virus WHO World Health Organization Publisher's Note Springer Nature"/>
  <result pre="draft. AL made literature review and wrote the draft on" exact="ocular" post="diseases and built TableÂ 2. GH reviewed and corrected"/>
  <result pre="draft for the biological part. FS is national referent in" exact="infectious diseases" post="for the French Armed Forces; he managed the working"/>
  <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
  <result pre="could be construed as potential competing interests. References References 1.DaubneyRHudsonJRGarnhamPCEnzootic" exact="hepatitis" post="or rift valley fever. An undescribed virus disease of"/>
  <result pre="References 1.DaubneyRHudsonJRGarnhamPCEnzootic hepatitis or rift valley fever. An undescribed virus" exact="disease" post="of sheep cattle and man from east AfricaJ Pathol"/>
  <result pre="east AfricaJ Pathol Bacteriol19313454557910.1002/path.1700340418 2.TantelyLMBoyerSFontenilleDA review of mosquitoes associated with" exact="Rift Valley fever" post="virus in MadagascarAm J Trop Med Hyg20159272272910.4269/ajtmh.14-042125732680 3.MonacoFPinoniCCossedduGMKhaisebSCalistriPMoliniUet al.Rift"/>
  <result pre="5.WrightDKortekaasJBowdenTAWarimweGMRift Valley fever: biology and epidemiologyJ Gen Virol20191001187119910.1099/jgv.0.00129631310198 6.Centers for" exact="Disease" post="Control (CDC). Biosafety in Microbiological and Biomedical Laboratories (BMBL),"/>
  <result pre="from Mali to Europe and other countries, 2016Eurosurveillance.201924180021310.2807/1560-7917.ES.2019.24.8.1800213 10.ChevalierVRelevance of" exact="Rift Valley fever" post="to public health in the European UnionClin Microbiol Infect20131970570810.1111/1469-0691.1216323517372"/>
  <result pre="European UnionClin Microbiol Infect20131970570810.1111/1469-0691.1216323517372 11.LiuJSunYShiWTanSPanYCuiSet al.The first imported case of" exact="Rift Valley fever" post="in China reveals a genetic reassortment of different viral"/>
  <result pre="Valley fever in China reveals a genetic reassortment of different" exact="viral" post="lineagesEmerg Microbes Infect.20176e410.1038/emi.2016.13628096531 12.WiwanitkitSEmerging Rift Valley fever in China:"/>
  <result pre="a genetic reassortment of different viral lineagesEmerg Microbes Infect.20176e410.1038/emi.2016.13628096531 12.WiwanitkitSEmerging" exact="Rift Valley fever" post="in China: what should be known?Asian Pac J Trop"/>
  <result pre="to the United Kingdom to support replication and transmission of" exact="Rift Valley fever" post="virusParasite Vectors.20181130810.1186/s13071-018-2884-7 14.HartleyDMRinderknechtJLNippTLClarkeNPSnowderGDcollab: National Center for Foreign Animal and"/>
  <result pre="virusParasite Vectors.20181130810.1186/s13071-018-2884-7 14.HartleyDMRinderknechtJLNippTLClarkeNPSnowderGDcollab: National Center for Foreign Animal and Zoonotic" exact="Disease" post="Defense Advisory Group on Rift Valley FeverPotential effects of"/>
  <result pre="Disease Defense Advisory Group on Rift Valley FeverPotential effects of" exact="Rift Valley fever" post="in the United StatesEmerging Infect Dis.201117e121801607 15.HartmanDARiceLMDeMariaJBorlandEMBergrenNAFagreACet al.Entomological risk"/>
  <result pre="Infect Dis.201117e121801607 15.HartmanDARiceLMDeMariaJBorlandEMBergrenNAFagreACet al.Entomological risk factors for potential transmission of" exact="Rift Valley fever" post="virus around concentrations of livestock in ColoradoTransbound Emerg Dis.2019661709171731002468"/>
  <result pre="and a new paradigm of research and development for zoonotic" exact="disease" post="controlEmerging Infect Dis.20131918919310.3201/eid1902.12094123347653 17.LaughlinLWMeeganJMStrausbaughLJMorensDMWattenRHEpidemic Rift Valley fever in Egypt:"/>
  <result pre="research and development for zoonotic disease controlEmerging Infect Dis.20131918919310.3201/eid1902.12094123347653 17.LaughlinLWMeeganJMStrausbaughLJMorensDMWattenRHEpidemic" exact="Rift Valley fever" post="in Egypt: observations of the spectrum of human illnessTrans"/>
  <result pre="human illnessTrans R Soc Trop Med Hyg19797363063310.1016/0035-9203(79)90006-3575446 18.AhmadKMore deaths from" exact="Rift Valley fever" post="in Saudi Arabia and YemenLancet2000356142210.1016/S0140-6736(05)74068-X11052595 19.MohamedMMoshaFMghambaJZakiSRShiehW-JPaweskaJet al.Epidemiologic and clinical"/>
  <result pre="Arabia and YemenLancet2000356142210.1016/S0140-6736(05)74068-X11052595 19.MohamedMMoshaFMghambaJZakiSRShiehW-JPaweskaJet al.Epidemiologic and clinical aspects of a" exact="Rift Valley fever" post="outbreak in humans in Tanzania, 2007Am J Trop Med"/>
  <result pre="MayotteBull Soc Pathol Exot201911215315510.3166/bspe-2018-008831825188 21.HimeidanYEKwekaEJMahgoubMMEl RayahEAOumaJORecent outbreaks of Rift Valley" exact="Fever" post="in East Africa and the Middle EastFront Public Health.2014216910.3389/fpubh.2014.0016925340047"/>
  <result pre="meta-analysis protocols (PRISMA-P) 2015 statementSyst Rev.201520154 23.World Health Organization (WHO)." exact="Rift Valley fever." post="https://www.who.int/news-room/fact-sheets/detail/rift-valley-fever. Accessed 31 Dec 2019. 24.Centers for Disease Control"/>
  <result pre="Rift Valley fever. https://www.who.int/news-room/fact-sheets/detail/rift-valley-fever. Accessed 31 Dec 2019. 24.Centers for" exact="Disease" post="Control (CDC). Outbreak Summaries Rift Valley Fever. https://www.cdc.gov/vhf/rvf/outbreaks/summaries.html. Accessed"/>
  <result pre="26 June 2019. 25.NanyingiMOMunyuaPKiamaSGMuchemiGMThumbiSMBitekAOet al.A systematic review of Rift Valley" exact="Fever" post="epidemiology 1931â€&quot;2014Infect Ecol Epidemiol.201552802426234531 26.MorvanJSaluzzoJFFontenilleDRollinPECoulangesPRift Valley fever on the"/>
  <result pre="coast of MadagascarRes Virol199114247548210.1016/0923-2516(91)90070-J1687082 27.MÃ©trasRCavalerieLDommerguesLMÃ©rotPEdmundsWJKeelingMJet al.The Epidemiology of Rift Valley" exact="Fever" post="in Mayotte: insights and perspectives from 11 years of"/>
  <result pre="Rift Valley FeverElectron J Diff Eq.2007115112 33.NiuTGaffHDPapelisYEHartleyDMAn epidemiological model of" exact="Rift Valley fever" post="with spatial dynamicsComput Math Methods Med.2012201213875710.1155/2012/13875722924058 34.LiJBlakeleyDSmithRJThe failure of"/>
  <result pre="Veille Sanitaire (InVS)Rift Valley feverMed Mal Infect.20114132232910.1016/j.medmal.2010.12.01021295425 37.Abdel-WahabKSEl BazLMEl-TayebEMOmarHOssmanMAYasinWRift Valley" exact="Fever" post="virus infections in Egypt: pathological and virological findings in"/>
  <result pre="(InVS)Rift Valley feverMed Mal Infect.20114132232910.1016/j.medmal.2010.12.01021295425 37.Abdel-WahabKSEl BazLMEl-TayebEMOmarHOssmanMAYasinWRift Valley Fever virus" exact="infections" post="in Egypt: pathological and virological findings in manTrans R"/>
  <result pre="in manTrans R Soc Trop Med Hyg19787239239610.1016/0035-9203(78)90134-7568328 38.SiamALMeeganJMGharbawiKFRift Valley fever" exact="ocular" post="manifestations: observations during the 1977 epidemic in EgyptBr J"/>
  <result pre="epidemiological, clinical, and laboratory characteristicsClin Infect Dis2003371084109210.1086/37874714523773 41.collab: Centers for" exact="Disease" post="Control and Prevention (CDC)Rift Valley fever outbreak-Kenya, November 2006â€&quot;January"/>
  <result pre="outbreak-Kenya, November 2006â€&quot;January 2007MMWR Morb Mortal Wkly Rep.200756737617268404 42.Centers for" exact="Disease" post="Control (CDC). Update: Outbreak of Rift Valley Fever Saudi"/>
  <result pre="42.Centers for Disease Control (CDC). Update: Outbreak of Rift Valley" exact="Fever" post="Saudi Arabia, August-November 2000. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4943a3.htm. Accessed 29 June 2019."/>
  <result pre="Arabia, August-November 2000. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4943a3.htm. Accessed 29 June 2019. 43.KahlonSSPetersCJLeducJMuchiriEMMuiruriSNjengaMKet al.Severe" exact="Rift Valley fever" post="may present with a characteristic clinical syndromeAm J Trop"/>
  <result pre="studyS Afr Med J197751867871561445 45.BoushabMBSavadogoMSowMSFall-MalickFZSeydiMSevere hemorrhagic form of Rift Valley" exact="Fever" post="in MauritaniaBull Soc Pathol Exot201510810210610.1007/s13149-015-0417-y25925806 46.RakotoariveloRAAndrianasoloRRazafimahefaSHRandremandranto RazafimbeloNSRandriaMJDSevere presentations of"/>
  <result pre="MauritaniaBull Soc Pathol Exot201510810210610.1007/s13149-015-0417-y25925806 46.RakotoariveloRAAndrianasoloRRazafimahefaSHRandremandranto RazafimbeloNSRandriaMJDSevere presentations of Rift Valley" exact="Fever" post="in MadagascarMed Mal Infect.20114131832110.1016/j.medmal.2010.12.00721295426 47.Al-HazmiMAyoolaEAAbdurahmanMBanzalSAshrafJEl-BushraAet al.Epidemic Rift Valley fever"/>
  <result pre="of Rift Valley Fever in MadagascarMed Mal Infect.20114131832110.1016/j.medmal.2010.12.00721295426 47.Al-HazmiMAyoolaEAAbdurahmanMBanzalSAshrafJEl-BushraAet al.Epidemic" exact="Rift Valley fever" post="in Saudi Arabia: a clinical study of severe illness"/>
  <result pre="study of severe illness in humansClin Infect Dis20033624525210.1086/34567112539063 48.NderituLLeeJSOmoloJOmuloSOâ€™GuinnMLHightowerAet al.Sequential" exact="Rift Valley fever" post="outbreaks in eastern Africa caused by multiple lineages of"/>
  <result pre="caused by multiple lineages of the virusJ Infect Dis201120365566510.1093/infdis/jiq00421282193 49.BabaMMasigaDKSangRVillingerJHas" exact="Rift Valley fever" post="virus evolved with increasing severity in human populations in"/>
  <result pre="Africa?Emerg Microbes Infect.20165e5810.1038/emi.2016.5727329846 50.MorrillJCIkegamiTYoshikawa-IwataNLokugamageNWonSTerasakiKet al.Rapid accumulation of virulent rift valley" exact="Fever" post="virus in mice from an attenuated virus carrying a"/>
  <result pre="genome analysis of 33 ecologically and biologically diverse Rift Valley" exact="Fever" post="virus strains reveals widespread virus movement and low genetic"/>
  <result pre="virus: unanswered questionsAntiviral Res201613227428010.1016/j.antiviral.2016.07.00527400990 53.LaBeaudADPfeilSMuiruriSDahirSSutherlandLJTraylorZet al.Factors associated with severe human" exact="Rift Valley fever" post="in Sangailu, Garissa County, KenyaPLoS Negl Trop Dis.20159e000354810.1371/journal.pntd.000354825764399 54.NjengaMKPaweskaJWanjalaRRaoCYWeinerMOmballaVet"/>
  <result pre="FeverRev Sci Tech Off Int Epiz20153437538910.20506/rst.34.2.2364 57.SmithDRSteeleKEShamblinJHonkoAJohnsonJReedCet al.The pathogenesis of" exact="Rift Valley fever" post="virus in the mouse modelVirology201040725626710.1016/j.virol.2010.08.01620850165 58.AyoolaAEAl-HazmiMHMichailNTAderojuAHafezMMBanzalSBLiver involvement in patients"/>
  <result pre="58.AyoolaAEAl-HazmiMHMichailNTAderojuAHafezMMBanzalSBLiver involvement in patients with moderately severe rift valley feverThe" exact="American" post="Journal of Gastroenterology.200398S92 59.ShraimMAEidRRadadKSaeedNUltrastructural pathology of human liver in"/>
  <result pre="60.ShiehW-JPaddockCDLedermanERaoCYGouldLHMohamedMet al.Pathologic studies on suspect animal and human cases of" exact="Rift Valley fever" post="from an outbreak in Eastern Africa, 2006â€&quot;2007Am J Trop"/>
  <result pre="61.BoushabBMFall-MalickFZOuld BabaSEWOuld SalemMLBelizaireMRDLedibHet al.Severe human illness caused by Rift Valley" exact="Fever" post="Virus in Mauritania, 2015Open Forum Infect Dis.2016320010.1093/ofid/ofw200 62.PhilippeBJouanARiouOCoulibalyILeguennoBMeeganJet al.Hemorrhagic"/>
  <result pre="in Mauritania, 2015Open Forum Infect Dis.2016320010.1093/ofid/ofw200 62.PhilippeBJouanARiouOCoulibalyILeguennoBMeeganJet al.Hemorrhagic forms of" exact="Rift Valley fever" post="in MauritaniaBull Soc Pathol Exot198982611619 63.StrausbaughLJLaughlinLWMeeganJMWattenRHClinical studies on Rift"/>
  <result pre="Valley fever in MauritaniaBull Soc Pathol Exot198982611619 63.StrausbaughLJLaughlinLWMeeganJMWattenRHClinical studies on" exact="Rift Valley fever," post="Part I: acute febrile and hemorrhagic-like diseasesJ Egypt Public"/>
  <result pre="Pathol Exot198982611619 63.StrausbaughLJLaughlinLWMeeganJMWattenRHClinical studies on Rift Valley fever, Part I:" exact="acute" post="febrile and hemorrhagic-like diseasesJ Egypt Public Health Assoc197853181182572398 64.AdamFJouanARiouOPhilippeBCoulibalyIBerliozBet"/>
  <result pre="Valley feverBull Soc Pathol Exot198982628636 65.JouanAPhilippeBRiouOCoulibalyILeguennoBMeeganJet al.Mild clinical forms of" exact="Rift Valley fever" post="during the epidemic in MauritaniaBull Soc Pathol Exot198982620627 66.Al-KhuwaitirTSAl-MoghairiAMSherbeeniSMAl-GhamdiASRift"/>
  <result pre="the epidemic in MauritaniaBull Soc Pathol Exot198982620627 66.Al-KhuwaitirTSAl-MoghairiAMSherbeeniSMAl-GhamdiASRift Valley fever" exact="hepatitis" post="complicated by disseminated intravascular coagulation and hepatorenal syndromeSaudi Med"/>
  <result pre="MauritaniaBull Soc Pathol Exot198982620627 66.Al-KhuwaitirTSAl-MoghairiAMSherbeeniSMAl-GhamdiASRift Valley fever hepatitis complicated by" exact="disseminated intravascular coagulation" post="and hepatorenal syndromeSaudi Med J20042552853115083233 67.AnyanguASGouldLHSharifSKNgukuPMOmoloJOMutongaDet al.Risk factors for"/>
  <result pre="and hepatorenal syndromeSaudi Med J20042552853115083233 67.AnyanguASGouldLHSharifSKNgukuPMOmoloJOMutongaDet al.Risk factors for severe" exact="Rift Valley fever" post="infection in Kenya, 2007Am J Trop Med Hyg201083142110.4269/ajtmh.2010.09-029320682901 68.SalemMLOBabaSEWOFall-MalickFZBoushabBMGhaberSMMokhtarASevere"/>
  <result pre="Med J20042552853115083233 67.AnyanguASGouldLHSharifSKNgukuPMOmoloJOMutongaDet al.Risk factors for severe Rift Valley fever" exact="infection" post="in Kenya, 2007Am J Trop Med Hyg201083142110.4269/ajtmh.2010.09-029320682901 68.SalemMLOBabaSEWOFall-MalickFZBoushabBMGhaberSMMokhtarASevere hemorrhagic"/>
  <result pre="casesPan Afr Med J.2016247327642413 69.De StMaurice AHarmonJNyakarahukaLBalinandiSTumusiimeAKyondoJet al.Rift valley fever" exact="viral" post="load correlates with the human inflammatory response and coagulation"/>
  <result pre="Valley fever encephalitisEmerging Infect Dis.20041055455510.3201/eid1003.02081715116716 71.RiouOPhilippeBJouanACoulibalyIMondoMDigoutteJPNeurologic and neurosensory forms of" exact="Rift Valley fever" post="in MauritaniaBull Soc Pathol Exot198982605610 72.MaarSASwanepoelRGelfandMRift Valley fever encephalitis."/>
  <result pre="description of a caseCent Afr J Med.197925811421266 73.LaughlinLWGirgisNIMeeganJMStrausbaughLJYassinMWWattenRHClinical studies on" exact="Rift Valley fever." post="Part 2: Ophthalmologic and central nervous system complicationsJ Egypt"/>
  <result pre="73.LaughlinLWGirgisNIMeeganJMStrausbaughLJYassinMWWattenRHClinical studies on Rift Valley fever. Part 2: Ophthalmologic and" exact="central nervous system" post="complicationsJ Egypt Public Health Assoc.197853183184572399 74.HanecheFLeparc-GoffartISimonFHentzienMMartinez-PourcherVCaumesEet al.Rift Valley fever"/>
  <result pre="Valley fever in kidney transplant recipient returning from Mali with" exact="viral" post="RNA detected in semen up to four months from"/>
  <result pre="from symptom onset, France, autumn 2015Eurosurveillance.201610.2807/1560-7917.ES.2016.21.18.3022227172608 75.ReedCLinKWilhelmsenCFriedrichBNalcaAKeeneyAet al.Aerosol exposure to" exact="Rift Valley fever" post="virus causes earlier and more severe neuropathology in the"/>
  <result pre="Trop Dis.20137e215610.1371/journal.pntd.000215623593523 76.HartmanALPowellDSBethelLMCarolineALSchmidRJOuryTet al.Aerosolized rift valley fever virus causes fatal" exact="encephalitis" post="in african green monkeys and common marmosetsJ Virol2014882235224510.1128/JVI.02341-1324335307 77.WileyCABhardwajNRossTMBisselSJEmerging"/>
  <result pre="encephalitis in african green monkeys and common marmosetsJ Virol2014882235224510.1128/JVI.02341-1324335307 77.WileyCABhardwajNRossTMBisselSJEmerging" exact="infections" post="of CNS: avian influenza A virus, Rift Valley Fever"/>
  <result pre="green monkeys and common marmosetsJ Virol2014882235224510.1128/JVI.02341-1324335307 77.WileyCABhardwajNRossTMBisselSJEmerging infections of CNS:" exact="avian influenza" post="A virus, Rift Valley Fever Virus and human parechovirusBrain"/>
  <result pre="77.WileyCABhardwajNRossTMBisselSJEmerging infections of CNS: avian influenza A virus, Rift Valley" exact="Fever" post="Virus and human parechovirusBrain Pathol20152563465010.1111/bpa.1228126276027 78.AlbeJRBoylesDAWaltersAWKujawaMRMcMillenCMReedDSet al.Neutrophil and macrophage"/>
  <result pre="human parechovirusBrain Pathol20152563465010.1111/bpa.1228126276027 78.AlbeJRBoylesDAWaltersAWKujawaMRMcMillenCMReedDSet al.Neutrophil and macrophage influx into the" exact="central nervous system" post="are inflammatory components of lethal Rift Valley fever encephalitis"/>
  <result pre="into the central nervous system are inflammatory components of lethal" exact="Rift Valley fever" post="encephalitis in ratsPLoS Pathog201915e100783310.1371/journal.ppat.100783331220182 79.WonderlichERCarolineALMcMillenCMWaltersAWReedDSBarratt-BoyesSMet al.Peripheral blood biomarkers of"/>
  <result pre="nervous system are inflammatory components of lethal Rift Valley fever" exact="encephalitis" post="in ratsPLoS Pathog201915e100783310.1371/journal.ppat.100783331220182 79.WonderlichERCarolineALMcMillenCMWaltersAWReedDSBarratt-BoyesSMet al.Peripheral blood biomarkers of disease"/>
  <result pre="fever encephalitis in ratsPLoS Pathog201915e100783310.1371/journal.ppat.100783331220182 79.WonderlichERCarolineALMcMillenCMWaltersAWReedDSBarratt-BoyesSMet al.Peripheral blood biomarkers of" exact="disease" post="outcome in a monkey Model of Rift Valley Fever"/>
  <result pre="of disease outcome in a monkey Model of Rift Valley" exact="Fever" post="encephalitisJ Virol201892e01662-1710.1128/JVI.01662-1729118127 80.WaltersAWKujawaMRAlbeJRReedDSKlimstraWBHartmanALVascular permeability in the brain is a"/>
  <result pre="of Rift Valley Fever encephalitisJ Virol201892e01662-1710.1128/JVI.01662-1729118127 80.WaltersAWKujawaMRAlbeJRReedDSKlimstraWBHartmanALVascular permeability in the" exact="brain" post="is a late pathogenic event during Rift Valley fever"/>
  <result pre="permeability in the brain is a late pathogenic event during" exact="Rift Valley fever" post="virus encephalitis in ratsVirology201952617317910.1016/j.virol.2018.10.02130396029 81.El ImamMEl SabiqMOmranMAbdalkareemAEl Gaili MohamedMAElbashirAet"/>
  <result pre="is a late pathogenic event during Rift Valley fever virus" exact="encephalitis" post="in ratsVirology201952617317910.1016/j.virol.2018.10.02130396029 81.El ImamMEl SabiqMOmranMAbdalkareemAEl Gaili MohamedMAElbashirAet al.Acute renal"/>
  <result pre="virus encephalitis in ratsVirology201952617317910.1016/j.virol.2018.10.02130396029 81.El ImamMEl SabiqMOmranMAbdalkareemAEl Gaili MohamedMAElbashirAet al.Acute" exact="renal failure" post="associated with the Rift Valley fever: a single center"/>
  <result pre="with the Rift Valley fever: a single center studySaudi J" exact="Kidney" post="Dis Transpl.2009201047105219861868 82.FreedIRift valley fever in man, complicated by"/>
  <result pre="rift valley feverS Afr Med J19512592693014892952 84.Al-HazmiAAl-RajhiAAAbboudEBAyoolaEAAl-HazmiMSaadiRet al.Ocular complications of" exact="Rift Valley fever" post="outbreak in Saudi ArabiaOphthalmology200511231331810.1016/j.ophtha.2004.09.01815691569 85.YoserSLForsterDJRaoNASystemic viral infections and their"/>
  <result pre="complications of Rift Valley fever outbreak in Saudi ArabiaOphthalmology200511231331810.1016/j.ophtha.2004.09.01815691569 85.YoserSLForsterDJRaoNASystemic" exact="viral" post="infections and their retinal and choroidal manifestationsSurv Ophthalmol19933731335210.1016/0039-6257(93)90064-E8387231 86.Newman-GerhardtSMuiruriSMuchiriEPetersCJMorrillJLucasAHet"/>
  <result pre="of Rift Valley fever outbreak in Saudi ArabiaOphthalmology200511231331810.1016/j.ophtha.2004.09.01815691569 85.YoserSLForsterDJRaoNASystemic viral" exact="infections" post="and their retinal and choroidal manifestationsSurv Ophthalmol19933731335210.1016/0039-6257(93)90064-E8387231 86.Newman-GerhardtSMuiruriSMuchiriEPetersCJMorrillJLucasAHet al.Potential"/>
  <result pre="and their retinal and choroidal manifestationsSurv Ophthalmol19933731335210.1016/0039-6257(93)90064-E8387231 86.Newman-GerhardtSMuiruriSMuchiriEPetersCJMorrillJLucasAHet al.Potential for" exact="autoimmune" post="pathogenesis of Rift Valley Fever virus retinitisAm J Trop"/>
  <result pre="manifestationsSurv Ophthalmol19933731335210.1016/0039-6257(93)90064-E8387231 86.Newman-GerhardtSMuiruriSMuchiriEPetersCJMorrillJLucasAHet al.Potential for autoimmune pathogenesis of Rift Valley" exact="Fever" post="virus retinitisAm J Trop Med Hyg20138949549710.4269/ajtmh.12-056223918215 87.RanjanRRanjanSOcular pathology: role"/>
  <result pre="88.KhairallahMLadjimiAChakrounMMessaoudRYahiaSBZaoualiSet al.Posterior segment manifestations of Rickettsia conorii infectionOphthalmology200411152953410.1016/j.ophtha.2003.04.01215019331 89.KhairallahMKahlounRBen YahiaSJellitiBMessaoudRNew" exact="infectious" post="etiologies for posterior uveitisOphthalmic Res201349667210.1159/00034400923258387 90.Galindo-CardielIBusquetsNVelardeRAbadFXSolanesDRivasRet al.Lymphoplasmacytic endotheliitis and"/>
  <result pre="manifestations of Rickettsia conorii infectionOphthalmology200411152953410.1016/j.ophtha.2003.04.01215019331 89.KhairallahMKahlounRBen YahiaSJellitiBMessaoudRNew infectious etiologies for" exact="posterior" post="uveitisOphthalmic Res201349667210.1159/00034400923258387 90.Galindo-CardielIBusquetsNVelardeRAbadFXSolanesDRivasRet al.Lymphoplasmacytic endotheliitis and anterior uveitis in"/>
  <result pre="infectious etiologies for posterior uveitisOphthalmic Res201349667210.1159/00034400923258387 90.Galindo-CardielIBusquetsNVelardeRAbadFXSolanesDRivasRet al.Lymphoplasmacytic endotheliitis and" exact="anterior uveitis" post="in sheep infected experimentally with rift valley fever virusJ"/>
  <result pre="etiologies for posterior uveitisOphthalmic Res201349667210.1159/00034400923258387 90.Galindo-CardielIBusquetsNVelardeRAbadFXSolanesDRivasRet al.Lymphoplasmacytic endotheliitis and anterior" exact="uveitis" post="in sheep infected experimentally with rift valley fever virusJ"/>
  <result pre="human abortionsTrans R Soc Trop Med Hyg19807468568610.1016/0035-9203(80)90167-47193926 93.BaudinMJumaaAMJommaHJEKarsanyMSBuchtGNÃ¤slundJet al.Association of" exact="Rift Valley fever" post="virus infection with miscarriage in Sudanese women: a cross-sectional"/>
  <result pre="Soc Trop Med Hyg19807468568610.1016/0035-9203(80)90167-47193926 93.BaudinMJumaaAMJommaHJEKarsanyMSBuchtGNÃ¤slundJet al.Association of Rift Valley fever" exact="virus infection" post="with miscarriage in Sudanese women: a cross-sectional studyLancet Glob"/>
  <result pre="Trop Med Hyg19807468568610.1016/0035-9203(80)90167-47193926 93.BaudinMJumaaAMJommaHJEKarsanyMSBuchtGNÃ¤slundJet al.Association of Rift Valley fever virus" exact="infection" post="with miscarriage in Sudanese women: a cross-sectional studyLancet Glob"/>
  <result pre="Hyg19807468568610.1016/0035-9203(80)90167-47193926 93.BaudinMJumaaAMJommaHJEKarsanyMSBuchtGNÃ¤slundJet al.Association of Rift Valley fever virus infection with" exact="miscarriage" post="in Sudanese women: a cross-sectional studyLancet Glob Health.20164e864e87110.1016/S2214-109X(16)30176-027692776 94.AdamIKarsanyMSCase"/>
  <result pre="women: a cross-sectional studyLancet Glob Health.20164e864e87110.1016/S2214-109X(16)30176-027692776 94.AdamIKarsanyMSCase report: Rift Valley" exact="Fever" post="with vertical transmission in a pregnant Sudanese womanJ Med"/>
  <result pre="pregnant Sudanese womanJ Med Virol20088092910.1002/jmv.2113218360907 95.ArishiHMAqeelAYAl HazmiMMVertical transmission of fatal" exact="Rift Valley fever" post="in a newbornAnn Trop Paediatr20062625125310.1179/146532806X12036316925964 96.WoodsCWKarpatiAMGreinTMcCarthyNGaturukuPMuchiriEet al.An outbreak of"/>
  <result pre="a newbornAnn Trop Paediatr20062625125310.1179/146532806X12036316925964 96.WoodsCWKarpatiAMGreinTMcCarthyNGaturukuPMuchiriEet al.An outbreak of Rift Valley" exact="Fever" post="in Northeastern Kenya, 1997â€&quot;98Emerg Infect Dis2002813814410.3201/eid0802.01002311897064 97.Al AzraqiTAEl MekkiAAMahfouzAARift"/>
  <result pre="adolescents in southwestern Saudi ArabiaJ Infect Public Health.2013623023510.1016/j.jiph.2012.11.01123668469 98.Centers for" exact="Disease" post="Control (CDC). Isolation precautions. Guidelines library. Infection Control. https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html."/>
  <result pre="Health.2013623023510.1016/j.jiph.2012.11.01123668469 98.Centers for Disease Control (CDC). Isolation precautions. Guidelines library." exact="Infection" post="Control. https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html. Accessed 30 June 2019. 99.Al-HamdanNAPanackalAAAl BassamTHAlrabeaAAl HazmiMAl"/>
  <result pre="Accessed 30 June 2019. 102.KendeMAlvingCRRillWLSwartzGMCanonicoPGEnhanced efficacy of liposome-encapsulated ribavirin against" exact="Rift Valley fever" post="virus infection in miceAntimicrob Agents Chemother19852790390710.1128/AAC.27.6.9034026264 103.HugginsJWProspects for treatment"/>
  <result pre="2019. 102.KendeMAlvingCRRillWLSwartzGMCanonicoPGEnhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever" exact="virus infection" post="in miceAntimicrob Agents Chemother19852790390710.1128/AAC.27.6.9034026264 103.HugginsJWProspects for treatment of viral"/>
  <result pre="102.KendeMAlvingCRRillWLSwartzGMCanonicoPGEnhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus" exact="infection" post="in miceAntimicrob Agents Chemother19852790390710.1128/AAC.27.6.9034026264 103.HugginsJWProspects for treatment of viral"/>
  <result pre="virus infection in miceAntimicrob Agents Chemother19852790390710.1128/AAC.27.6.9034026264 103.HugginsJWProspects for treatment of" exact="viral" post="hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drugRev Infect"/>
  <result pre="antiviral compoundSci Rep.20188192510.1038/s41598-018-20362-929386590 107.SchartonDBaileyKWVestZWestoverJBKumakiYVan WettereAet al.Favipiravir (T-705) protects against peracute" exact="Rift Valley fever" post="virus infection and reduces delayed-onset neurologic disease observed with"/>
  <result pre="107.SchartonDBaileyKWVestZWestoverJBKumakiYVan WettereAet al.Favipiravir (T-705) protects against peracute Rift Valley fever" exact="virus infection" post="and reduces delayed-onset neurologic disease observed with ribavirin treatmentAntiviral"/>
  <result pre="WettereAet al.Favipiravir (T-705) protects against peracute Rift Valley fever virus" exact="infection" post="and reduces delayed-onset neurologic disease observed with ribavirin treatmentAntiviral"/>
  <result pre="against peracute Rift Valley fever virus infection and reduces delayed-onset" exact="neurologic disease" post="observed with ribavirin treatmentAntiviral Res2014104849210.1016/j.antiviral.2014.01.01624486952 108.SmeeDFJungK-HWestoverJGowenBB2â€²-Fluoro-2â€²-deoxycytidine is a broad-spectrum"/>
  <result pre="peracute Rift Valley fever virus infection and reduces delayed-onset neurologic" exact="disease" post="observed with ribavirin treatmentAntiviral Res2014104849210.1016/j.antiviral.2014.01.01624486952 108.SmeeDFJungK-HWestoverJGowenBB2â€²-Fluoro-2â€²-deoxycytidine is a broad-spectrum"/>
  <result pre="a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral" exact="disease" post="mouse modelsAntiviral Res2018160485410.1016/j.antiviral.2018.10.01330339848 109.BorregoBde Ã�vilaAIDomingoEBrunALethal mutagenesis of Rift Valley"/>
  <result pre="disease mouse modelsAntiviral Res2018160485410.1016/j.antiviral.2018.10.01330339848 109.BorregoBde Ã�vilaAIDomingoEBrunALethal mutagenesis of Rift Valley" exact="Fever" post="Virus induced by favipiravirAntimicrob Agents Chemother.201963e00669-1910.1128/AAC.00669-1931085519 110.AtkinsCFreibergANRecent advances in"/>
  <result pre="Chemother.201963e00669-1910.1128/AAC.00669-1931085519 110.AtkinsCFreibergANRecent advances in the development of antiviral therapeutics for" exact="Rift Valley fever" post="virus infectionFuture Virol.20171265166510.2217/fvl-2017-006029181086 111.AllenERKrummSARaghwaniJHalldorssonSElliottAGrahamVAet al.A protective monoclonal antibody targets"/>
  <result pre="a site of vulnerability on the surface of Rift Valley" exact="Fever" post="VirusCell Rep.2018253750â€&quot;3758e4 112.KareshJWMazzoliRAHeintzSKOcular manifestations of mosquito-transmitted diseasesMil Med201818345045810.1093/milmed/usx18329635625 113.SimonFJavelleECabieABouquillardETroisgrosOGentileGet"/>
  <result pre="mosquito-transmitted diseasesMil Med201818345045810.1093/milmed/usx18329635625 113.SimonFJavelleECabieABouquillardETroisgrosOGentileGet al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations)Med Mal Infect.20154524326310.1016/j.medmal.2015.05.00726119684 114.HassanMMAgarwalAAfridiRMdaSilvaMJBKaracaISadiqMAet al.The role"/>
 </snippets>
</snippetsTree>
